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ABSTRACT
BIOMONITORING POLYBROMINATED DIPHENYL ETHERS IN
LACTATING WOMEN
by
Rebecca L. Dunn 
University of New Hampshire, September 2008 
Breast milk is a valuable biological specimen for biomonitoring lipid- 
soluble polybrominated diphenyl ethers (PBDEs). The goal of this project was to 
determine the levels of PBDEs in breast milk of lactating women from the 
Seacoast region of New Hampshire and to examine potential relationships 
between PBDE levels in breast milk and stage of lactation, maternal 
characteristics, living environment and dietary intake. Forty women, ages 22 to 
40, provided up to three breast milk samples at the end of their first, second and 
third month of breastfeeding for evaluation of day-to-day and month-to-month 
variation in PBDE levels. Participants were asked to complete four 
questionnaires, which provided maternal, living environment, and diet 
information. The sum of PBDE (IPBDE) congeners found in breast milk was 
defined as: BDE-28/33, 47, 85, 99, 100, 153, 154, and 183. The IPBDE 
concentrations in breast milk over the three-month collection period ranged from 
6.5 to 166.7 ng/g lipid. The median for the three-month period was 29.7 ng/g. 
BDE-47 was the predominant congener; however, BDE-153 predominated in 
20% of the participants’ samples from each month. Day-to-day variation in 
IPBDEs was negligible; there was no significant difference in mean PBDE levels 
from month-to-month. Regression analyses revealed relationships between log-
XI
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transformed PBDE levels in breast milk and questionnaire data. Positive 
associations were seen between BDE-153 and age (r= 0.36 p = 0.02), saturated 
fat consumption (r= 0.31 p = 0.05), and the home model (r= 0.51 p = 0.004). 
There was a negative association between PBDE levels ( I  and BDE-47) and 
fruit consumption (r= 0.36 p = 0.02, IPBDE). Our results indicate that PBDE 
levels in breast milk from New Hampshire are within the range that has been 
reported in the U.S., and that levels are stable during the first three-months of 
lactation. Our findings revealed a higher predominance pattern with BDE-153 
compared to other studies, and indicate that PBDE levels are influenced by age, 
diet, and the home environment.
XII
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CHAPTER I 
INTRODUCTION
Polybrominated diphenyl ethers (PBDEs) are synthetic flame retardants 
that are added to consumer products, such as fabrics, foams, and electronics. 
Over time, PBDEs can diffuse out of their products, become airborne or enter 
dust, and disperse into the environment and into humans. Due to their 
persistent, lipid-soluble characteristics and widespread use in consumer 
products, PBDEs are bioaccumulating and have been detected in air, dust, 
mammals, and humans -  including human breast milk.
Breast milk is a valuable biological specimen for biomonitoring lipid- 
soluble PBDEs. The purpose of biomonitoring is to document, update, and 
expand human exposure information on environmental chemicals (U.S. 
Department of Health and Human Services, Centers for Disease Control and 
Prevention [U.S. DHHS, CDC], 2005); breast milk biomonitoring studies can 
estimate PBDE exposure in both the nursing mother and breastfeeding infant, 
but can also provide information about sources of PBDE exposure.
In the U.S., a limited number of studies have reported PBDE levels in 
breast milk, with no documentation to date from the state of New Hampshire.
One study in the U.S. has reported rates of PBDE elimination overtime in a small 
sample of nursing mothers from California (Hooper et al., 2007), and one has 
demonstrated relationships between PBDE levels in breast milk and house dust,
1
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dairy intake, and meat intake (Wu et al., 2007). Given the limited number of 
studies in the U.S., there is a need to further document PBDE levels in humans, 
examine PBDE levels in breast milk over time, and further evaluate potential 
sources of PBDE exposure, all of which contribute to the purpose of 
biomonitoring.
The goals of Biomonitoring PBDEs in Lactating Women were to contribute to 
the current body of knowledge about PBDE levels in breast milk of lactating 
women and to examine potential relationships between PBDE levels in breast 
milk and maternal characteristics, living/occupational environment and dietary 
intake. This research will provide new knowledge about PBDE levels in the state 
of New Hampshire. Specific objectives of the research were:
1.) To develop an informative, yet reassuring tool to educate potential subjects 
about the research being done, body burden, PBDEs, and the importance of 
breastfeeding.
2.) To determine the levels of PBDEs in breast milk of lactating women from the 
Seacoast region of New Hampshire.
3.) To evaluate the relationship between PBDE levels in breast milk and stage 
of lactation.
4.) To evaluate the relationship between PBDE levels in breast milk and 
maternal characteristics.
5.) To evaluate the relationship between PBDE levels in breast milk and dietary 
intake.
6.) To evaluate the relationship between PBDE levels in breast milk and 
maternal environment.
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CHAPTER II
REVIEW OF THE LITERATURE 
biomonitorinq
Biological monitoring, or biomonitoring is the measurement of 
environmental chemicals, their metabolites, or their reaction products in the 
human body, specifically through blood, urine, saliva, breast milk, adipose or 
other tissue (Needham et al., 2007; U.S. DHHS, CDC, 2005). The CDC (2005) 
defines an environmental chemical as “a chemical compound or chemical
element that is present in air, water, food, soil, dust or other environmental media
/
(e.g., consumer products)” (p.1). The steady increase in the production and use 
of chemicals in the U.S. since World War II, particularly industrial and agricultural 
chemicals, has encouraged biomonitoring initiatives worldwide.
The purpose of biomonitoring is to document, update and expand human 
exposure information on environmental chemicals. Specific uses of 
biomonitoring data have been identified by the CDC, which are to: a.) determine 
which chemicals are in the U.S. population and at what levels; b.) determine the 
prevalence of people with levels of chemicals that are above known toxicity 
levels; c.) establish reference ranges of chemicals that allows for identification of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
a person or group with high exposure; d.) determine if human exposure levels 
are higher among some groups as compared to others; e.) follow time trends in 
levels of human exposure; and f.) set research priorities on human health effects 
(U.S. DHHS, CDC, 2005). Assessing human exposure to environmental 
chemicals is an important aspect of the exposure-effect continuum (Figure 1) 
(Needham et al., 2007; Sexton et al., 2004).
Exposure source
water, air, food, soil, dust, sediment, personal 
care products, in utero
Exposure surfaces:











Note. Adapted from “Strategic Biomonitoring Initiatives: Moving the Science Forward," by J. Angerer, M.G. Bird, T. Burke, N.G. Doerrer,
L.L. Needham, S.H. Robison, L  Sheldon, and H. Zenick, 2006, Toxicobgical Sdences, 93, p. 5. Copyright 2006 by Oxford Univa^ity Press.
Figure 1. Exposure to health effect continuum.
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With more than 80,000 chemicals in use, numerous government- 
sponsored programs have been initiated in the U.S. to meet public and private
) ■
demands for biomonitoring including: the National Health and Nutrition 
Examination Survey, the National Environmental Tracking Program, the National 
Children’s Study, the Agricultural Health Study, the Farm Family Exposure Study, 
the National Human Exposure Assessment Survey, and the Center for Children’s 
Environmental Health and Disease Prevention Research (Albertini et al., 2006). 
Biomonitoring has many uses in the area of environmental public health; it seeks 
to expand the current state of knowledge on assessing human exposure to 
chemicals (internal dose), exposure sources and pathways, and potential health 
effects (Figure 1 ) (Needham et al., 2007).
Assessing Human Exposure
The CDC’s National Biomonitoring Program is continuously assessing the 
U.S. population’s exposure to environmental chemicals through the collection of 
biological samples (blood and urine). The CDC began biomonitoring in 1976 
through the second National Health and Nutrition Examination Survey (NHANES
ft
II) by measuring blood lead levels in a representative sample of the U.S. 
population (Sexton et al., 2004). Biomonitoring continued with NHANES III, but 
data collection was sporadic until 1999 when NHANES became a continuous 
survey gathering data on a new national sample every two years.
In March 2001, the CDC’s Environmental Health Laboratory released the 
first National Report on Human Exposure to Environmental Chemicals, which 
provided biomonitoring data on 27 chemicals (U.S. DHHS, CDC, 2001). The
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report provided exposure levels on 27 environmental chemicals for the U.S. 
population. Since this time, two additional reports have followed with the most 
recent released in July 2005, which provided exposure data in a sampling of 
2,400 people for 148 environmental chemicals (U.S. DHHS, CDC, 2005).
The groups of environmental chemicals in the third report included the 
following: metals; tobacco smoke; polycyclic aromatic hydrocarbons; 
polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and coplanar 
and mono-ortho-substituted polychlorinated biphenyls; non-dioxin-like 
polychlorinated biphenyls; phthalates; phytoestrogens; organochlorine pesticides; 
organophosphate pesticides; herbicides; pyrethroid pesticides; other pesticides; 
and carbamate insecticides (U.S. DHHS, CDC, 2005). The chemicals for 
biomonitoring in the first three reports were selected based on scientific data. In 
upcoming reports, however, chemicals will have been nominated by the public, 
and prioritized and selected by a panel of experts from the CDC. 
Recommendations have been set forth by the National Research Council (2006) 
to include other agencies for chemical selection, such as the Environmental 
Protection Agency, the National Toxicology Program, the Food and Drug 
Administration, the U.S. Department of Agriculture and the National Institute of 
Environmental Health Sciences. With an interagency approach to selecting 
priority chemicals, this will enhance the overall purpose of biomonitoring. 
Assessing Exposure Sources and Surfaces
Needham and colleagues (2005) described exposure as the contact 
between a source and a target where contact occurs at an exposure surface
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
during an exposure period. As depicted in Figure 1, an exposure source is 
water, air, food, soil, dust, sediment, personal care products, and in utero 
exposure. Humans (targets) encounter exposure sources depending on various 
events in their lifetime (exposure period) which allows for uptake through 
exposure surfaces (e.g. nasal passages, mouth and skin).
Biomonitoring data can assist in examining overall exposure sources and 
surfaces; it works in the reverse direction on the exposu re-effect continuum by 
going from human exposure to exposure source (Albertini et al., 2006; Needham 
et al., 2007). Biomonitoring data that is coupled with other assessment methods, 
such as questionnaires and personal monitoring can provide information that 
potentially links internal dose to exposure source.
The collection of serial analytical measurements of exposure sources are 
necessary for identifying concentrations, variability, and trends of environmental 
chemicals, which can assist in developing health indices (Bahadori et al., 2007; 
Needham et al., 2007). For example, the U.S. Environmental Protection 
Agency’s (U.S. ERA) reference dose can provide an estimate of a daily exposure 
level that is npt expected to cause adverse health effects over one’s lifetime 
(Needham et al., 2007). The relationship between one’s exposure, the expected 
internal dose concentration, and the potential health implications are of particular 
interest to environmental public health scientists.
Assessing Potential Health Effects through Biomonitorinq
In the Third National Report on Human Exposure to Environmental 
Chemicals, the CDC (2005) states, “the measurement of an environmental
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chemical in a person’s blood or urine does not by itself mean that the chemical 
causes disease ” (p. 4). One of the greatest challenges with biomonitoring is 
evaluating the potential health implications of the data.
The ability to interpret the results of biomonitoring data in the context of a 
health risk assessment lags behind current analytical methodology (Hays et al., 
2007). Human health risk assessment of environmental chemicals can use an 
interpretative method that compares estimated daily doses to health-based 
criteria for acceptable, safe, or tolerable intakes. These comparisons can assess 
whether estimated doses exceed health screening levels. However, 
biomonitoring data measures environmental chemical concentrations in biological 
specimens (e.g. blood, urine) rather than estimated intake doses.
Quantitative criteria are needed for interpretation of environmental 
chemical concentrations in biological specimens and their relevance to human 
health. In order for these criteria to be developed, advances are necessary in the 
following areas: toxicologic, epidemiologic and toxicokinetic data, health-based 
values such as reference doses, health-risk data, and exposure assessment data 
(National Research Council, 2006). The National Research Council (2006) 
describes two primary options for interpreting biomonitoring data, which are the 
descriptive approach and the risk-based approach.
The descriptive approach offers a statistical presentation of the data 
(National Research Council, 2006). For example, in the Third National Report on 
Human Exposure to Environmental Chemicals (2005), descriptive statistics, such 
as geometric mean and percentiles, are used to present the data. The use of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
percentiles allows for the data to be distributed in reference ranges. Reference 
ranges offer a point of comparison for individuals and subgroups, and also allows 
health care professionals to determine high levels of exposure (National 
Research Council, 2006; U.S. DHHS, CDC, 2005). The descriptive approach is 
an important step in the interpretation of biomonitoring data; it begins to lay the 
groundwork for risk-based approaches (National Research Council, 2006).
The risk-based approach is complex, as it uses toxicologic, epidemiologic, 
or pharmacokinetic modeling information (National Research Council, 2006). 
These methods evaluate the risk that is associated with the amount of 
environmental chemical present in the body.
There are several interpretative risk-based options: biomonitoring-based 
risk assessment, traditional risk assessment, and biomonitoring-led n'sk 
assessment (National Research Council, 2006). Biomonitoring-based risk 
assessment uses biomarker-response relationships that have been established 
in epidemiologic studies; however, there are only a few environmental chemicals 
that have enough data to use this approach to interpret risk. Traditional risk 
assessment evaluates exposure pathways to estimate the human dose; the dose 
is then used to calculate health risk as compared to health-based criteria for 
acceptable, safe, and tolerable intakes. The third option, biomonitoring-led risk 
assessment, uses quantitative data on the absorption, distribution, metabolism, 
and excretion (pharmacokinetics) of an environmental chemical. With this option, 
pharmacokinetic modeling techniques are used to convert biomonitoring data into 
a format, such as a human-exposure dose format, that provides exposure
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information in risk assessments. Biomonitoring-led risk assessment relies upon 
an expansive biomonitoring and toxicology database for the environmental 
chemical of interest; therefore, its uses could be limited depending upon the 
availability of data for an environmental chemical.
Typically, interpretation of biomonitoring data ends with the observation 
that the chemical is present in humans (descriptive approach), which becomes 
the message that is communicated to the public, and can often induce anxiety. 
The challenge for environmental health scientists is to interpret the health 
implications of biomonitoring data and appropriately communicate the results to 
the public (National Research Council, 2006).
Communicating Results of Biomonitorinq Studies
Biomonitoring data presents the results of environmental chemical levels 
in humans; this makes human exposure data personal (National Research 
Council, 2006). Brody and colleagues (2007) address the ethical challenges that 
are associated with reporting personal exposure information for environmental 
chemicals. Deciding whether or not to report individual levels of environmental 
chemicals requires researchers to consider several principles for protecting 
human participants: autonomy; beneficence; nonmalfeasance; and justice.
The principles of autonomy and justice support the practice of providing 
participants with their individual results (Brody et al., 2007). Autonomy is an 
individual’s right to know in order to make decisions based upon the research 
results while justice emphasizes the provision of information that highlights the 
benefits and harms as it applies to different groups of people. The principles of
10
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autonomy and justice are typically seen in community-based participatory 
research and activist exposure studies where participants receive their individual 
results.
The clinical medicine model emphasizes the principles of beneficence and 
nonmalfeasance in which participants may not be provided with their individual 
results (Brody et al., 2007). These principles support the practice of maximizing 
benefits and minimizing potential harm, particularly when the meaning of results 
is unclear; and can lead to situations that cause fear, anxiety, and unnecessary 
interventions.
The challenge with each of these principles is balancing the benefits and 
harms that are associated with reporting individual exposure levels; this balance 
should be based on the available research for the environmental chemical. 
However, regardless of whether individual or group levels are reported, it is 
important to ensure that communication of results includes proper interpretation 
and use of biomonitoring data.
The National Research Council (2006) emphasizes early planning as an 
important component in communicating biomonitoring information. Early 
planning enables researchers to assess the needs of the study population and to 
establish partnerships with other constituencies in formulating public health 
messages. Early planning also encourages researchers to consider both 
practical and research-based communication recommendations.
Practical recommendations focus on educational aspects, whereas, 
research-based recommendations promote the advancement of biomonitoring
11
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communication (National Research Council, 2006). Practical biomonitoring 
communication recommendations highlight the following areas; communication 
sponsorship, use of consistent terminology and concepts, expansion of 
biomonitoring education to the public, communication training for organizations 
and professionals, and public documentation of ways to reduce exposures. 
Research-based recommendations emphasize the following areas: identification 
of scientist and non-scientist beliefs about exposures and health effects, 
assessment of current biomonitoring communication methods and its impact on 
the public, identification of the public’s perception regarding uncertainties in 
biomonitoring, and identification of the public’s beliefs about risk reduction. In 
addition to these recommendations, Bates and colleagues (2005) further suggest 
that researchers communicate accessible results of biomonitoring research. For 
example, researchers should distinguish between statistically significant effects 
and clinically significant effects. These recommendations are a crucial 
component in creating and building an infrastructure for communicating results of 
biomonitoring studies.
If communication is lacking between biomonitoring researchers and the 
general public, then the results of biomonitoring studies are subject to 
misinterpretation and misuse, which can lead to public health messages that 
induce confusion, conflict and anxiety. For example, occasionally, the media will 
become aware of biomonitoring research, and will provide a condensed, 
simplified version of the results (Bates et al., 2005). Often, these types of 
messages present a communication risk, particularly if the biological specimen is
12
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sensationalized with a degree of harm, which can happen when environmental 
chemicals are detected in breast milk.
breast milk biomonitorinq 
The use of breast milk as a biological matrix for biomonitoring studies can 
estimate environmental chemical exposure in both the nursing mother and 
breastfeeding infant. Determining infant exposure can be done by measuring the 
concentration of the environmental chemical in breast milk and estimating infant 
intake of milk (Lovelady et al., 2002).
Breast milk can be a convenient and noninvasive means for estimating 
environmental chemical exposures as compared to other biological matrices, 
which may require surgical intervention. (Hooper & She, 2003). However, it is 
important that sampling does not burden the mother or compromise the infant’s 
nutrition. There are guidelines that should be considered when determining the 
study design of breast milk biomonitoring programs.
Studv Design Considerations
Participant Characteristics. There are a number of influential participant 
characteristics that can affect environmental chemical concentrations in breast 
milk samples. Fenton et al. (2005), Lovelady et al. (2002), and the World Health 
Organization (WHO) (2004; 2007) have described characteristics that should be 
taken into account when measuring environmental chemicals in breast milk. 
Fenton and colleagues (2005) list the following characteristics that should be 
considered: maternal information such as age and body mass index, lifestyle 
history such as dietary intake, smoking, and medication use, obstetric history.
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occupational history, and prior breastfeeding history. The WHO (2004; 2007) 
provides specific recommendations for participant characteristics in breast milk 
biomonitoring studies including: first-time mothers, healthy mother and infant, 
mothers under the age of 30, and primarily or exclusively breastfeeding. The 
most recent WHO (2007) guidelines recommend that mothers should have 
resided in the same geographical location for at least the past 10 years, although 
the residency time frame could pose a challenge for recruiting young mothers 
who are under the age of 30 into breast milk biomonitoring studies. In addition to 
considering maternal characteristics for breast milk biomonitoring studies, it is 
recommended that researchers implement a milk collection protocol.
Breast Milk Expression and Collection. Lovelady and colleagues (2002) 
recommend collecting and analyzing individual breast milk samples from women 
rather than pooling samples. Pooling samples is less expensive than analysis of 
individual samples, but analyzing individual milk samples enables researchers to 
examine potential associations between participant characteristics and 
environmental chemical levels. It is also important for researchers to consider 
individual expression and collection variables that can affect milk composition.
Study design recommendations have suggested hand-expressing 
samples for breast milk biomonitoring research in order to limit sample 
contamination from breast pumps. However, recent research by Hooper and 
colleagues (2007) found that breast pumps can be used for expression of 
samples as they maintain accuracy of environmental chemical levels when 
compared to hand-expressed samples. Use of a breast pump is recommended if
14
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researchers wish to receive samples that contain hind milk, which have a higher 
fat content than foremilk (Lovelady et al., 2002). Obtaining a sample that 
contains hind milk is useful when analyzing lipid-soluble environmental chemicals 
and usually requires a complete milk expression from one breast. This method 
of milk collection enables researchers to estimate exposure of lipid-soluble 
environmental chemicals in individual infants: however, it is not a typical practice 
when examining concentrations in the mother because levels are presented on a 
lipid-adjusted basis. Participant compliance and retention are greater when 
breast pumps are provided for milk collection, and are especially helpful for 
women who find manual pumping difficult.
Participant retention can be dependent on timing of sample collection. 
Lovelady et al. (2002) and the WHO (2007) suggest waiting until week two or 
three to begin sampling to ensure that lactation has been well established. It is 
also recommended to collect samples within the first three- months postpartum 
as early weaning and lower exclusive breastfeeding rates can often be a 
recruitment and retention factor in breast milk biomonitoring studies, particularly 
in the U.S. For example, data collected in the U.S. from the National 
Immunization Survey in 2004, reported that 30.5% of infants were exclusively 
breastfed at three months, which then decreased to 11.3% at six months of age 
(U.S. DHHS, CDC, 2007). Therefore, collecting breast milk samples in the first 
few months postpartum could lead to higher participant retention rates.
Lovelady et al. (2002) suggests collecting samples at different time 
intervals, such as at month one, two and three, to evaluate for changes in
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
environmental chemical levels over time. Additionally, the time of day and time 
elapsed between feedings should be consistent among participants as these 
variables have been found to contribute to daily variations in the fat content of 
milk samples, which is an important consideration when assessing exposure of 
lipid-soluble environmental chemicals in individual infants. Ruel and colleagues 
(1997) found that the average concentration of fat in a 24-hour pooled sample 
was 4.2%: the time of day that was in agreement with this percentage was 
between the hours of 6 a.m. and 8 a.m. Since breast milk composition varies 
from feed to feed, day to day, and month to month, it is recommended to 
standardize the sample collection period.
Prior to collecting milk samples, participants should be provided with 
guidelines for washing the breast and equipped with proper storage containers 
for their milk samples. Lovelady and colleagues (2002) recommend that mothers 
wash the breast with a mild, detergent-free soap, and rinse the breast with 
distilled water to limit potential contamination from creams and ointments. 
Additionally, it is recommended that participants be provided with suitable 
storage containers. The U.S. EPA (2003) and the WHO (2007) suggest amber 
glass bottles that have Teflon fitted lids and have been detergent-water washed, 
then solvent-rinsed prior to use. The recommendations for containers are 
necessary as some environmental chemicals are sensitive to ultraviolet light, and 
if lipid-soluble, may adhere to plastic containers during their handling and 
storage.
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Breast Milk Sample Handling. Storage and Analysis. Once breast milk 
samples are placed into the appropriate storage container with a participant 
identification number, they can then be stored in a refrigerator for up to 72 hours 
(4°C) or placed in the freezer (-20°C) (WHO, 2007). Frozen breast milk samples 
can be stored at -70° for an indefinite period (Lovelady et al., 2002). 
Transportation of frozen samples should be on dry ice.
There are several analytical methods for measuring environmental 
chemicals in breast milk; however, regardless of the selected approach, the 
process typically consists of the following general steps: 1.) sample preparation, 
which includes lipid determination and “cleanup”; 2.) sample analysis, which 
involves chromatographic and detection steps; and 3.) data analysis and 
evaluation (Needham & Wang, 2002). Selecting an analytical method depends 
upon the classification of the analytes of interest. Environmental chemicals can 
be classified as inorganic or organic compounds, and further categorized as 
volatile or semi-volatile organic environmental chemicals. Regardless of the 
analytes of interest and the selected analytical approach, there should be 
methodological goals built into the measurement process that address quality 
assurance and control to determine specificity, sensitivity, precision, and 
accuracy of the technique.
Advantages and Disadvantages of Breast Milk Biomonitorinq Programs
Breast milk Is a valuable matrix for monitoring body burdens of 
environmental chemicals; however, there are positive and negative aspects when 
using breast milk to assess human exposure to environmental chemicals (Fenton
17
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et al., 2005; Hooper & She, 2003). Fenton and colleagues (2005) identify the 
following limitations: 1.) interpretation and communication of study results, which 
have the potential for affecting breastfeeding rates if inaccurate messages are 
provided to the public; 2.) recruitment challenges if studies are limited to women 
who are exclusively breastfeeding; 3.) sampling challenges if analytes of interest 
have short half-lives; 4.) insufficient data on depuration (elimination kinetics), 
which limits estimates on infant intake; and 5.) the inability to generalize the 
results given the selected marker of exposure. Even though there are limitations 
associated with breast milk biomonitoring studies, several positive aspects have 
been identified: 1.) the collection of serial samples, which provides information on 
environmental chemical levels overtime; 2.) the use of one biological specimen 
to assess exposure of the mother and infant; 3.) a better understanding of body 
burden of breastfed infants; and 4.) the collection of a biological specimen with a 
high fat content, which is an important consideration for lipid-soluble 
environmental chemicals -  particularly those that have been steadily rising in 
their production, use, and presence in the environment and in humans, such as 
synthetic flame retardants.
flame retardants
Every twenty seconds, a fire department responds to a fire somewhere in 
the U.S. (Karter, 2006). In 2005, fires were responsible for 3,675 civilian-related 
deaths, 17,925 civilian injuries, and greater than 10 billion dollars in property 
damage. Since 1977, fire incidence has decreased from 3,264,000 to 1,602,000 
due to fire prevention polices that require the presence of flame retardant
18
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Chemicals in a variety of different products (Birnbaum & Staskal, 2004; Karter,
2006).
Flame retardants are synthetic chemicals that are added to materials 
either during or after manufacturing in order to interfere with the combustion 
process (Bromine Science and Environmental Forum [BSEF], 2000). This 
interference can occur during heating, decomposition, ignition or flame spread. 
There are over 175 different types of flame retardants that are divided into four 
major classes: halogenated organic (usually brominated or chlorinated), 
phosphorus-containing, nitrogen-containing, and inorganic flame retardants 
(Birnbaum & Staskal, 2004; BSEF, 2000). The brominated flame retardants 
(BFRs) are the most widely used due to their low cost and high performance 
efficiency. Compared to other flame retardants, consumer products use a smaller 
quantity of BFRs for a higher fire resistance (BSEF, 2000).
Brominated Flame Retardants
There are five major classes of BFRs, including brominated bisphenols, 
cyclododecanes, phenols, phthalic acid derivatives, and diphenyl ethers 
(Birnbaum & Staskal, 2004). The most widely used BFRs are 
tetrabromobisphenol A, hexabromocyclododecane, and three commercial 
products of polybrominated diphenyl ethers known as decabromodiphenyl ether, 
octabromodiphenyl ether and pentabromodiphenyl ether (Birnbaum & Staskal, 
2004; BSEF, 2000). In 2001, polybrominated diphenyl ethers (PBDEs) 
represented one of the highest production volumes of BFRs in the U.S. with a 
total market consumption of 33,100 metric tons (BSEF, 2003).
19
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Polybrominated Diphenyl Ethers
There is the potential for 209 PBDE yariants. Each yariant can be 
identified by the number and position of bromine atoms, also known as a PBDE 




Key: PBDE variants; x + y = 1 t o 1 0  bromines
Figure 2. General structure of PBDEs
Howeyer, there are fewer PBDE congeners in commercial mixtures than 
theoretically possible due to their instability and debromination (Birnbaum & 
Staskal, 2004). Three commercial PBDE products - pentaBDE, octabBDE and 
decaBDE - contain mixtures of yarious PBDE congeners, are used in different 
products, and yary in their market demand (Table 1).
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The total U.S. market demand values for pentaBDE and octaBDE are expected 
to drop to zero because Great Lakes Chemical Corporation, the soie U.S. 
manufacturer of pentaBDE and octaBDE, discontinued production of these two 
commercial products at the end of 2004 (U.S. EPA, 2006).
Even though PBDEs have been in use since the 1970s, they have 
captured the attention of policymakers, firefighters and the general public, 
worldwide, over the past 15 years. The European Union adopted legislation in 
2002 that prohibited the use of pentaBDE and octaBDE, which took effect in 
August 2004 (U.S. EPA, 2006). Several states in the U.S. have also adopted 
bans on the distribution of products that contain pentaBDE and octaBDE, 
including California, Maine and New York. Although decaBDE has the highest 
annual global demand at 56,100 metric tons (83% of PBDE demand) (BSEF, 
2003), restrictions on its use has been limited. The European Union granted an 
exemption on prohibiting the use of decaBDE in October 2005 (U.S. EPA, 2006), 
but Washington state recently became the first in the U.S. to have approved 
legislation that would ban the use of decaBDE in household goods, which is 
scheduled to take effect in 2008 (American Chemical Society, 2007). The 
legislation was supported by Washington state fire chiefs and firefighters. Even 
though the presence of PBDEs in consumer products such as television sets, 
carpet padding, mattresses, chair and couch foams, computers, stereos, and hair 
dryers saves lives each year in the U.S., there are concerns with its widespread 
use because of increasing environmental and human concentrations.
22
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Bioaccumulation. Due to their persistent, iipid-soiuble characteristics and 
incorporation into a variety of products, PBDEs are bioaccumùlating. PBDE 
bioaccumulation is primarily due to PBDE release from consumer products into 
the air through normal use, degradation, disposai, and recyciing; additional 
release can also occur during PBDE manufacturing and incorporation into 
products (Hale et al., 2003). PBDEs are non-chemically bound additives, and 
may contribute up to 30% by weight of foams, fabrics and plastics (Hale et al., 
2003; Hooper & She, 2003). Over time, PBDEs can diffuse out of their products, 
become airborne or enter dust, and disperse into the environment and into 
humans.
PBDEs have been detected in air, house dust, sewage sludge, water, 
sediment, and soil (Allen et al., 2007; de Boer et al., 2003; Hale et al., 2002; 
Jones-Otazo et al., 2005; Rudel et al., 2003; Wù et al., 2007). It Is suggested 
that ingestion of indoor dust is a major exposure pathway for PBDEs in humans 
(Allen et al., 2007; Jones-Otazo et al., 2005) and that hand-to-mouth exposure 
contributes to people’s Intake of PBDEs (Stapleton et al., 2008).
Studies document PBDE appearance in marine mammals, fish, pet cats, 
human tissue, human placenta, and human blood samples (Bradman et al.,
2007; Dye et al., 2007; Gômara et al., 2007; Guvenius et al., 2003; Johnson- 
Restrepo et al., 2005; Mazdai et al., 2003; Petreas et al., 2003; Rice et al., 2002; 
Sandanger et al., 2007; Schecter et al., 2007; Schecter et al., 2005; She et al., 
2002; Sjôdin et al., 1999; Sjôdin et al., 2004; Strand man et al., 2000). Time- 
trend data from the U.S. indicate increasing PBDE biood concentrations between
23
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1973 and 2003, and between 1985 and 2002 (Schecter et al., 2005; Sjôdin et al., 
1999).
PBDEs have been detected in various samples of food sources from 
Japan, Spain & U.S. (Bocio et al., 2003; Hu we & Larsen, 2005; Huwe et al.,
2002; Ohta et al., 2002; Schecter et al., 2006; Schecter et al., 2004). Bocio and 
colleagues (2003) found that foods of animal origin, fish, and fats and oiis have 
higher ievels of PBDEs as compared to grains, fruits and vegetables. Higher 
PBDE levels were ejected by Ohta and colleagues (2002) In fish sampies as 
compared to beef and chicken; however, spinach, potato and carrot had higher 
PBDE concentrations as compared to beef and chicken. Recent work by 
Schecter et al. (2006) confirmed that the highest PBDE levels in a U.S. market 
basket survey were detected in fish samples followed by dairy products and 
meat. PBDEs have also been detected in another biologicai matrix - studies from 
Canada, China, Czech Repubiic, Denmark, Faroe Isiands, Finland, Italy, Japan, 
Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom and U.S. report that 
PBDEs appear in human breast milk (Akutsu et al., 2003; Bi et al., 2006; Chao et 
al., 2007; ErdogruI et al., 2004; Eslami et al., 2006; Fângstrôm et al., 2005; 
Gômara et al., 2007; Hooper et al., 2007; Ingelido et al., 2007; Jaraczewska et 
al., 2006; Johnson-Restrepo et al., 2007; Kalantzi et al., 2004; Kazda et al.,
2004; Lind et al., 2003; Lunder & Sharp, 2003; Main et al., 2007; Meironyté et al., 
1999; Norén & Meironyté, 2000; Ohta et al., 2002; Ryan & Patry, 2000; Ryan et 
al., 2006; Schecter et al., 2005; Schecter et al., 2003; Schuhmacher et al., 2007; 
She et al., 2007; Strand man et al., 2000; Wu et al., 2007).
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Levels of PBDEs in humans vary geographically, however, the highest 
PBDE concentrations in humans have been reported in the U.S. (Hites, 2004). 
With the appearance of PBDEs in the environment and concentrations in 
humans, this raises concern about the potential human health implications.
Heaith Implications. With a simiiar chemicai structure to polychiorinated 
biphenyls (PCBs) and pesticides such as dichlorodiphenyltrichloroethane (DDT), 
both of which have been banned due to their adverse heaith outcomes (Hooper 
& McDonaid, 2000), as weil as structural similarities to thyroid hormone, research 
is necessary to understand the human heaith impiications of PBDEs -  which are 
currently unknown.
There are a limited number of epidemiological studies, to date, that have 
examined PBDE concentrations and human health. In central Taiwan, increased 
PBDE levels in human breast milk were related to lower birth weight and length, 
head and chest circumference, and body mass index in newborns (Chao et al., 
2007). A recent study by Main and coileagues (2007) revealed that the 
concentration of PBDEs in breast miik was significantly higher in infant boys with 
congenital cryptorchidism as compared to controls. A case-control study by, 
Harden and colleagues (2001) found higher BDE-47 ievels in adipose 
tissue/biood sampies from adult Swedish patients with non-Hodgkin’s iymphoma 
when compared to age-matched controls. Furthermore, it was shown that the 
median titer to Epstein-Barr early antigen was higher among cases than controls, 
and the highest risk for non-Hodgkin’s lymphoma was found with high BDE-47
25
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concentrations and an elevated titer of antibodies to the Epstein-Barr virus 
antigen.
Research on the biologicai effects of PBDEs has been conducted mostly 
in experimental animal models. PBDEs have been shown to cause adverse 
effects in severai biological end-points. The greatest concern for the potential 
health implications of PBDEs comes from research that has examined 
developmental neurotoxicity in mice (Birnbaum & Staskal, 2004). Exposure to 
PBDEs adversely affects spontaneous behavior, and causes learning and 
memory deficits in mice (Branchi et al., 2002; Eriksson et al., 2001, Viberg et al., 
2003; Viberg et al., 2006). The mechanisms for these behavioral and cognitive 
deficits are not known, but research suggests alterations in cholinergic receptors, 
arachidonic acid reiease, and thyroid hormone homeostasis (Birnbaum &
Staskal, 2004).
Thyroid hormones influence a variety of physiological processes In the 
body such as regulating cellular metabolism and its crucial role in the 
development of the central nervous system. Research has demonstrated that 
hypothyroidism during pregnancy can adversely affect a child’s subsequent 
performance on neuropsychological tests (Haddow et al., 1999). PBDEs have 
been shown to disrupt thyroid hormone homeostasis in rats and mice. Studies 
have shown alterations in thyroid hormone levels, particularly decreased 
thyroxine levels, after exposure to PBDEs (Fowles et al., 1994; Hallgren et al., 
2001 ; S karman et al., 2005; Zhou et al., 2001 ; Zhou et al., 2002). There are 
several different mechanisms as to how PBDEs interact with thyroid hormone
2 6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
homeostasis, including alterations in piasma transport of thyroxine, induced 
hepatic enzyme activities resulting in increased metabolism of thyroxine, and 
possibiy direct effects on the thyroid gland (Darnerud et al., 2007; Lllienthal et al., 
2006; Meerts et al., 2000).
In addition, PBDE-induced imbalances in steroid hormone homeostasis
i . . . .
and other steroid-related effects have been documented in vivo and in vitro. A 
recent study by Lllienthal and colleagues (2006) documented the effect of BDE- 
99 on sex steroids, sexual development, and sexually dimorphic behavior in the 
offspring of treated pregnant rats. Exposure to PBDEs resulted in decreased 
circulating concentrations of estradiol and testosterone in male offspring, delayed 
puberty onset in female offspring, a reduction in the number of primordial/primary 
and secondary ovarian follicles, and an increased sweet preference in male 
offspring. The increased sweet preference in male offspring was characterized 
as sexually dimorphic behavior indicating behavioral feminization. Meerts and 
colleagues (2001) examined the estrogenicity activity of 17 PBDE congeners and 
3 hydroxylated PBDEs in vitro using an estrogen-responsive luciferase cell line.
It was found that cellular exposure to PBDE congeners and hydroxylated PBDEs 
induced the estrogen receptor signal transduction pathway in vitro. The most 
potent effects were seen with BDE-100, BDE-75, BDE-51, BDE-119 and the T 3- 
like and Ta-like hydroxylated PBDE compounds. The potential endocrine- 
disrupting effects of PBDEs could impact growth and development of the central 
nervous system and reproductive tissues as well as metabolism.
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In 2002, a hypothesis was generated on the role of synthetic chemicals in 
the giobai obesity epidemic (Baiilie-Hamilton, 2002). Hoppe and Carey (2007) 
pursued this hypothesis with the notion that PBDEs disrupt hormonally-mediated 
adipose tissue metabolism. After male rats were exposed to pentaBDE daily for 
4 weeks, an increase in lipolysis and a decrease in insulin sensitivity was seen, 
which is consistent with the metabolic effects observed in obese animals.
Further research is currently being pursued in this area, so the long-term effects 
of PBDEs on adipose tissue metabolism and its relationship to the promotion of 
obesity are not yet clear.
There is limited information as to how PBDE toxicity in animals translates 
to human health effects. McDonald (2005) recently examined PBDE exposure 
and risk assessment by comparing PBDE concentrations in humans with 
concentrations that were associated with developmental neurotoxicity and 
reproductive effects in rodents. Estimates of human daily PBDE intake was 
calculated from biomonitoring literature on PBDE concentrations in serum, 
adipose tissue, and breast milk from women in the U.S. Daily intake data for all 
human matrices were combined and the 95*^  percentile was determined, which 
represented high-end exposures in the U.S. population. The 95‘*^ percentile 
depicted the iipid-normalized PBDE concentrations in humans, which was 
compared to an estimate of lipid-normalized tissue concentrations in rodents. 
The rodent-to-human ratio of PBDE tissue concentration was then used as a 
margin of exposure. The margin of exposure was defined as how many folds 
higher is the rodent dose that caused no effects from the human dose; the
28
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
smaller the distance between doses the greater the heaith concern. Using this 
reverse dosimetry pharmacokinetic modeling approach, McDonald (2005) found 
that there was a small margin of exposure for behavioral and reproductive effects 
with alterations in maie fertility and ovary cells in females. A risk-assessment 
approach such as this enables researchers to evaluate biomonitoring data from a 
toxicity standpoint.
Toxicoioqv. The toxicology of the three commercial mixtures (pentaBDE, 
octaBDE, and decaBDE) and some of the individual PBDE congeners has been 
reviewed extensively by Darnerud et al. (2001), Gill et al. (2004), and Hardy 
(2002). The toxicological effects correspond with degree of bromination; the 
toxicity of the tetra through deca PBDE congeners decreases with increasing 
levels of bromination.
The toxicological effects of PBDEs have primarily been documented in 
animal models with almost no available data in humans (Birnbaum & Cohen 
Hubai, 2006). Overall, the acute toxicity of the commercial products is low when 
administered through the oral, dermal or pulmonary routes; however, differences 
exist between the three commercial products and their toxicological effects in 
repeated dose studies (Darnerud et al., 2001 ; Gill et al., 2004; Hardy, 2002). For 
example, oral administration of decaBDE appears to be less acutely toxic as 
compared to penta and octaBDE. Oral administration of decaBDE to mice and 
rats at 10% and 5% of their diet for 14 and 90 days, respectively, produced no 
adverse effects on appearance, behavior, body weight gain, and food 
consumption (U.S. DHHS, National Toxicology Program, 1986); however, chronic
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(2 years) dietary exposure to decaBDE has displayed evidence of 
carcinogenicity. Orai administration studies have aiso been conducted in rats 
with dietary exposure to octaBDE with doses of up to 1000 mg/kg/day (WHO,
1994). These studies have shown no effect on appearance, behavior, or 
mortality, however, hepatotoxicity was observed. Zhou and colleagues (2001) 
examined the dose-response relationships of 4-day exposure to the three 
commercial mixtures on thyroid hormone concentration and hepatic enzyme 
activities. The octa and pentaBDE formulations caused dose-dependent 
reductions of thyroxine and inductions of hepatic enzymatic activity.
Out of the three commercial mixtures, penta and octaBDE appear to have 
the most pronounced dose-dependent toxicity effects in subacute and subchronic 
animal studies (Darnerud et al., 2001; Gill et al., 2004; Hardy, 2002). The 
differences in toxicity effects are likely due to variations in absorption, 
metabolism, and elimination of the individual PBDE congeners from each of the 
commercial mixtures.
Absorption. Metabolism and Excretion. PBDE toxicokinetics (absorption, 
elimination, and enzyme induction and metabolism) has been studied primarily in 
experimental animal models, both in vitro and in vivo. Oral absorption and 
metabolism of the individual PBDE congeners varies depending upon the degree 
of bromination (Gill et al., 2004). Once PBDE exposure has occurred, it's been 
reported that the higher the degree of bromination, the lower the absorption rate 
(Birnbaum & Staskal, 2004). Historically, decaBDE has been shown to be poorly 
absorbed through the oral route due to its high molecular mass (Darnerud et al..
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2001; U.S. DHHS, National Toxicology Program, 1986); however, recent 
research has demonstrated that decaDBE can be absorbed orally at greater than 
10% of the dose in rats (Morck et ai., 2003). Lower brominated congeners, such 
as BDE-47 (tetra) and BDE-99 (penta), have been shown to have an oral 
absorption rate of 93% and greater than 50% in mouse and rat models, 
respectively (Hakk et al., 2002; ôrn & Klasson-Wehler, 1998). A higher 
absorption rate of lower brominated PBDE congeners leads to a greater 
likelihood for tissue bioaccumulation.
Lipophilic tissues tend to be the preferred sites for PBDE disposition; 
however, recent work by Inoue and coiieagues (2006) evaluated molecular 
descriptors (e.g. hydrophilicity, molecular size, poiar surface area) for PBDEs in 
human serum and breast milk samples, and found correlations with the 
milk/serum partition coefficients. The structure-activity relationship suggested 
that PBDE values in serum and breast milk are related to each other; however, 
BDE-209 was the predominant congener in serum and BDE-47 was the . 
predominant congener in breast milk.
The congener with the greatest concentration in most biological tissues is 
BDE-47, followed by BDE-99 or BDE-153 depending on the species (Hakk et al., 
2002; Hites, 2004). In 2002, Hakk and colleagues found that BDE-99 had the 
highest tissue concentrations in adipose, adrenals, gastrointestinal tract, and skin 
in male rats; however, the distribution pattern of BDE-99 did not consistently 
correlate with tissue lipid content. Other studies have shown similar results with 
regard to PBDE disposition and its preference to lipophilic tissues. Orn and
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Klasson-Wehler (1998) found that BDE-47 had the highest concentration in 
adipose tissue, but it was also detected in lung, kidney and brain tissues. Both of 
these studies also examined routes of elimination, it was found that fecai and 
urinary excretion were the routes of PBDE elimination, both the parent 
compounds and their metabolites.
The commercial PBDE mixtures and selected individual congeners have 
been shown to Induce Phase I cytochrome P450 monooxygenase (GYP) 
enzymes and Phase II conjugation enzymes in the liver, which are responsible 
for detoxification (Hakk & Letcher, 2003). The penta and octaBDE commercial 
mixtures have been shown to induce GYP enzymes (GYP1A1, GYP1A2, 
GYP2B1) in rats as indicated by increased activity of liver microsomes, such as 
ethoxyresorufin-O-deethyiase and pentoxyresorufin-O-deethylase, as well as 
Phase II induction of uridinediphosphate-glucuronosyltransferase (von Meyerinck 
et al., 1990; Zhou et al., 2001). When Zhou and colleagues (2001) compared the 
three PBDE commercial mixtures, they found that decaBDE had no significant 
effects on the measured Phase 1 and Phase 2 enzymes. At the present time, 
little is known on PBDE toxicokinetics in humans; however, studies have 
examined the estimated half-lives of PBDEs.
Estimated Half-Lives, it is known that PBDEs bioaccumuiate in humans, 
but the rate of absorption, the degree of tissue disposition, hepatic enzyme 
induction, and metabolism are not known. However, PBDE half-iives have been 
estimated in humans. Thuresson and coiieagues (2006) calculated the half-lives 
for higher brominated PBDEs (deca, nona, octa, and hepta congeners) using
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serum data from occupationally exposed workers who were sampled before, 
during, and after a vacation period. It was found that BDE-209 (deca) had a 
short half-life of 11 to 18 days, followed by 18 to 39 days for nona congeners, 37 
to 91 days for the octa congeners, and 68 to 120 days for BDE-183 (hepta). 
Therefore, the pattern that was observed by Thuresson et al. (2006) indicated the 
higher the number of bromine atoms for the PBDE congeners the shorter their 
half-lives in serum samples. Data has been presented by Geyer and colleagues 
(2004) on the half-lives of the lower brominated PBDE congeners (tetra, penta, 
and hexa). Using pharmacokinetic modeling estimates, it was found that the total 
body half-lives for tetra to hexa congeners were 1.8 to 6.5 years, respectively. 
These results are consistent with McDonald’s (2002) theory that some of the 
PBDEs have half-lives that are on the order of years. Since PBDEs can be 
absorbed and deposited in human tissue for extended lengths of time, 
biomonitoring programs are clearly warranted to assess the extent of exposure.
biomonitorinq PBDEs via breast milk 
Breast milk is a valuable biological specimen for biomonitoring PBDEs 
given their lipid-solubie characteristics. PBDEs in breast milk were first reported 
by Kruger (1988) in German samples, and later by Meironyté et al. (1999) In 
Swedish samples. PBDE concentrations in Swedish breast milk samples 
increased from 1972 to 1997, and it was determined that levels were doubling 
every five years whiie levels of other environmental chemicals (PCBs and DDT) 
were decreasing during this same time period (Meironyté et al., 1999; Norén & 
Meironyté, 2000). Documenting this exponential increase has resulted in PBDE
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breast milk biomonitoring initiatives around the globe. These initiatives have 
focused on: 1.) PBDE levels in breast milk of nursing mothers; 2.) rates of PBDE 
eiimination (depuration) from mothers during iactation; 3.) infant intake of PBDEs; 
and 4.) potential PBDE sources of exposure.
PBDE Levels in Breast Milk of Nursing Mothers
During the past decade, breast milk biomonitoring has enabled 
researchers to document and update human exposure information on PBDE 
levels in nursing mothers (Table 2). Currently, the levels of PBDEs in breast miik 
samples from the U.S. are 10 to 40 times higher than other regions such as_ 
Europe and Japan. The reason for the higher leveis of PBDEs in the U.S. is 
thought to be due to the market demand for these flame retardants as they are 
incorporated into numerous industrial and household products (Johnson- 
Restrepo et al., 2007). PBDE concentrations in the U.S. indicate differences in 
median values depending on the geographical location. For example, median 
PBDE values are higher from the Pacific Northwest compared to Massachusetts 
(Table 2) (Johnson-Restrepo et al., 2007; She et al., 2007; Wu et al., 2007). 
However; one consistent outcome that has been verified in the majority of breast 
milk biomonitoring studies, to date, is the predominance of the BDE-47 congener. 
Rates of PBDE Elimination from Mothers during Lactation
In addition to documenting PBDE leveis in breast milk. Hooper and 
colleagues (2007) recently reported rates of PBDE elimination from nursing 
mothers; this is the first study to measure PBDE depuration in mothers during 
lactation. Depuration was examined by measuring PBDE concentrations in serial
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breast milk samples from two groups (short-term and long-term) of first-time 
nursing mothers. The short-term group (n = 9) collected seven samples at fixed 
intervals from weeks 4 to 24. The long-term group (n = 9) collected initial 
samples 1 to 6 weeks after birth, and final samples 18 to > 85 weeks later. 
Additionally, two more groups of mothers collected samples 3 to 28 days after 
birth and 29 to 56 days after birth to examine depuration rates early in iactation.
Patterns of mean PBDE ievels in serial breast milk samples were 
examined over time. The predominant congener was BDE-47 and it correlated 
with the total sum of PBDEs. Therefore, BDE-47 was used to show depuration 
rates. Hooper and colleagues (2007) concluded that body burden of PBDEs 
were lowered by lactation; however, depuration of PBDEs by lactation is siow, 
averaging 1 to 3% per month or a 12 to 18% decrease after 6 months of 
breastfeeding. Depuration rates of PBDEs in the earlier stages of lactation were 
not higher as compared to later in iactation. It was suggested that infant intake of 
PBDEs for a second child would not be markedly lower as compared to the first 
child.
Infant Intake of PBDEs
According to Loveiady et al. (2002), breast milk biomonitoring data should 
not be used to assess infant exposure if oniy one milk sample has been collected 
at one time point because environmentai chemical concentrations can decrease 
over the course of lactation. Four breast milk biomonitoring studies have 
reported the estimated daily intake of PBDEs for infants (Chao et al., 2007; 
Johnson-Restrepo et al., 2007; Main et al., 2007; Meironyté et al., 1999). Breast
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milk biomonitoring studies tend to focus on estimating body burden of the 
mother, rather than assessing infant exposure, which provides an explanation for 
the limited number of studies that are available documenting an infant’s intake of 
PBDEs from breast milk.
Meironyté and colleagues (1999) estimated that the average daily intake 
of PBDEs from pooled breast milk samples for a 5 kg infant increased from 0.3 
ng/kg body weight in 1972 to 16.8 ng/kg body weight in 1997. More recently, 
Main et al. (2007) estimated the median daily intake of PBDEs for a three-month 
old infant to be 16 ng/kg body weight, which was calculated from one breast milk 
sample that consisted of several small aliquots collected over successive 
feedings. Chao and colleagues (2007) reported a daily intake of PBDEs for a 
breastfed newborn infant to be 20.6 ng/kg body weight; however, it’s assumed 
that only one 25 ml sample was collected from each mother. Based on median 
PBDE concentrations in breast miik samples from Massachusetts, Johnson- 
Restrepo et al. (2007), estimated a one-month old infant’s intake to be 4 ng/kg 
body weight for selected congeners (BDE-47, 99, and 153), but it’s not known 
how many samples were collected from each participant.
At this time, additional research is needed to estimate infant intake of 
PBDEs, specificaiiy studies that coilect serial breast milk samples over time. 
Estimating infant intake of PBDEs provides information on an infant’s body 
burden; however, determining infant exposure to environmentai chemicals via 
breastfeeding and the potentiai health implications warrants a longitudinal 
research design, an assessment of prenatal exposure (usually via cord blood).
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and the measurement of environmental chemicals in breast milk at several time 
points during lactation (Lovelady et al., 2002).
Potential PBDE Sources of Exposure
Breast milk biomonitoring researchers have evaiuated PBDE exposure 
sources through assessment questionnaires (Akutsu et ai., 2003; Bi et al., 2006; 
Chao et al., 2007; ErdogruI et al., 2004; Eslami et al., 2006; Fângstrôm et al., 
2005; Ingelido et al., 2007; Jaraczewska et al., 2006; Kalantzi et al., 2004; Lind et 
al., 2003; Lunder & Sharp, 2003; Main et al., 2007; Ohta et al., 2002; Schecter et 
al., 2003; Schuhmacher et al., 2007; She et al., 2007; Wu et al., 2007) and one 
recent study also analyzed house dust concentrations (Wu et al., 2007).
Exposure assessment questionnaires have evaluated the following: a.) dietary 
intake; b.) personal characteristics (e.g. age, anthropometries, parity, 
menstruation); c.) personal habits (e.g. smoking, alcohol consumption); d.) 
household and work environments (e.g. presence and number of eiectronics); e.) 
place of residence (e.g. urban or industrial zones); and/or f.) season in which 
infant was breastfed. Only a few studies have found significant relationships 
between PBDE levels in breast miik and exposure sources. The most significant 
relationships that have been documented are with house dust concentrations, 
dietary intake and smoking.
Wu and colleagues (2007) found a strong and positive correiation between 
PBDE concentrations in breast miik and house dust suggesting that the indoor 
home environment plays an important role in PBDE exposure. Twelve 
participants out of 40 agreed to dust sampiing in this study, and those
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participants with high PBDE dust concentrations had PBDE levels in breast milk 
that were 2.6 times higher as compared to those homes with lower dust 
concentrations.
In the same study, associations were also found between PBDE 
concentrations in breast milk and dairy intake as well as total meat consumption 
(Wu et al., 2007). The strongest association was found with dairy intake, which 
suggested a 3.6-fold increase in PBDE levels per daily ounce of dairy fat 
consumed. In addition to dairy intake, total meat consumption was also 
associated with an increase in PBDE levels per serving. For every 2 to 3 ounces 
of meat consumed, there was a 1.5-fold increase in PBDE levels. Other dietary 
factors, such as total fish consumption, were not significantly associated with 
PBDE levels in breast milk. However, in a small sampling of women from Japan, 
PBDE concentrations were significantly elevated with a higher frequency of fish 
consumption (every day) as compared to PBDE concentrations of women with a 
relatively low fish consumption (1 to 2 days per week) (Ohta et al., 2002). Few 
other studies have detected an association between PBDE levels in breast milk 
and dietary factors, but personal habits have indicated a relationship.
Lind and colleagues (2003) found a significant relationship between 
smoking and PBDE levels in breast milk. Even though the square of the 
correlation coefficient was low, it increased from 10 to 17% after the addition of 
smokers into the multiple regression model. Research continues to further 
examine PBDE exposure sources to better understand what contributes to 
human exposure.
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Advancing Breast Milk Biomonitorina Research
In the U.S., four peer-reviewed research studies have reported PBDE 
levels in breast milk (Table 2). One study in the U.S. has reported rates of PBDE 
elimination over time in a small sample of nursing mothers from California 
(Hooper et al., 2007), and one has demonstrated relationships between PBDE 
levels in breast milk and house dust, dairy intake, and meat intake (Wu et al.,
2007). Given the limited number of PBDE breast milk biomonitoring studies in 
the U.S. and no studies to date from the state of New Hampshire, there is a need 
to further document PBDE levels in humans, examine PBDE levels in breast milk 
over time, and further evaluate potential sources of PBDE exposure, all of which 
will be addressed in this research.
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One of the primary research objectives of this project was to develop an 
informative, yet reassuring tool to educate potential subjects about the research. 
Indeed, the intent of the research was not to undermine breastfeeding and scare 
mothers away from nursing their infants.
To address this objective, an undergraduate independent study student, 
who worked with the Carey Laboratory in the spring 2005 semester, assisted with 
developing the communication pamphlet. The format of the pamphlet contained 
short sections about the research study, body burden, what PBDEs are and 
where they come from, why we are measuring PBDEs, and the importance of 
breastfeeding. The final draft of the communication pamphlet also included a 
section on “frequently asked questions”.
As part of the communication pamphlet development phase, we 
collaborated with a health promotion advisor from the New Hampshire 
Department of Health and Human Services (NH DHHS), a faculty member from 
the Family Research Laboratory at the University of New Hampshire (UNH), the 
New Hampshire Breastfeeding Task Force and a focus group of women from the 
community. This collaboration provided us with valuable feedback on the content 
of the pamphlet, language and our overall research design.
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Our first collaborative meeting was in March 2005 with the NH DHHS 
health promotion advisor and the faculty member from the Family Research 
Laboratory. Their primary recommendations were to eliminate the technical 
language in order to decrease the reading level from 12*^  grade to 8*^  grade. In 
addition, they recommended that the pamphlet be visually appealing and be 
reassigned a less scientific name. The project’s secondary name became Steps 
to a Healthy Future.
Our second meeting was in April 2005 with 20 members of the New 
Hampshire Breastfeeding Task Force. The members of the Task Force are 
primarily registered nurses and registered dietitians who are lactation specialists. 
This meeting provided valuable input regarding appropriate breastfeeding 
language and further elimination of technical wording. During this meeting, 
members of the Task Force also provided helpful suggestions on our research 
design including sample collection time, sample size, breastfeeding support to 
participants and information on personal use vs. rental breast pumps.
Our third meeting was in May 2005 when we conducted a six person, one 
hour focus group to assess the content of the pamphlet. We recruited women 
from the UNH campus who were currently breastfeeding or had breastfed their 
child within the last two years. We provided background information on the 
study, reviewed each section of the communication pamphlet, and collected 
verbal and written feedback from the focus group participants. The verbal 
feedback emphasized refinement of language to further improve the readability of 
the communication pamphlet. The written feedback was collected by having
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participants complete an anonymous 10-question survey (Appendix A) about the 
content and clarity of the pamphlet at the end of the focus group session. The 
written feedback directed us to emphasize the health effects of PBDEs, 
participant time commitment and what will happen with the final results of the 
study.
The communication pamphlet was completed in August of 2005. The 
final format was an eight page pamphlet with readability statistics at the 5“  ^grade 
reading level (Appendix B). Approximately 1500 copies of the pamphlet were 
distributed to lactation consultants and placed in eight locations around the 
Seacoast area of New Hampshire (Dover Pediatrics, Exeter Hospital Family 
Center, Harbour Women’s Health, Lamprey Health Care, Portsmouth Regional 
Hospital, Rochester Women, Infants & Children Clinic, Seacoast Area La Leche 
League, and Wentworth Douglass Hospital) for subject recruitment.
recruitment
Participants were recruited from the Seacoast region of New Hampshire 
from November 2005 to July 2006. Recruitment was accomplished by lactation 
consultants from three area hospitals -  Exeter Hospital, Portsmouth Regional 
Hospital, and Wentworth Douglass Hospital -, distribution of the communication 
pamphlet, and word of mouth. The study protocol was approved by the UNH 
Institutional Review Board (IRB # 3433) and approval from each hospital was 
obtained prior to working with the lactation consultants. I attended monthly 
breastfeeding classes at each of the hospitals to provide research study
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information and the communication pamphlet to pregnant women. The lactation 
consultants also provided the communication pamphlet to postpartum women 
prior to their discharge from the hospital. In addition, the pamphlet was 
distributed to outpatient health care clinics.
participants
Women, ages to 22 to 40 from the Seacoast region of New Hampshire, 
who were in the early stages of lactation (less than 2 weeks) or in their last 
trimester of pregnancy and planned to breastfeed for at least the first three- 
months postpartum, were eligible for the study. Participant eligibility criteria also 
included delivering a full-term, healthy infant and planning to provide greater than 
80% of breast milk as the primary source of nutrition for the first three-months.
To show our appreciation for participation in the study, enrolled subjects 
were provided with an Ameda Purely Yours® personal use electric breast pump 
and kit. Each kit contained one personal use electric breast pump with a dual 
hygienic milk collection system, six 4-ounce clear, plastic bottles, a power 
adapter, an insulated tote with cooler pack, and a carry bag. Participants had the 
opportunity to talk with a professional lactation consultant during their enrollment 
in the study.
study design, procedures and analytical methods
Participants were asked to visit with researchers on four occasions over a 
three-month period for a total of approximately four hours (Figure 1 ). '
Researchers could meet with participants at their homes or at UNH.
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Visit 1 : Study orientation, obtained consent, administered Maternai Characteristics Survey & Food Frequency 
Questionnaire #1, measured body weight, provided personal use eiectric breast pump and kit
Visit 2: Sample pick-up (1 or 3 samples), provided Environment Survey
Visit 3: Sample pick-up (1 or 3 samples), retrieved Environment Survey
Visit 4: Sample pick-up (1 or 3 samples), administered Food Frequency Questionnaire #2, measured body weight,
study debriefing
Figure 1. Study design from recruitment to visit 4.
The first visit occurred at three weeks postpartum. During the first visit, 
participants were oriented to the study’s purpose and design, compieted a food 
frequency questionnaire and a maternai characteristics survey, were weighed on 
a Heaith o meter® mechanical floor-level scale, and signed a UNH IRB subject 
consent form (Appendix C). Participants received verbai and written instruction 
on breast milk expression via the personal use eiectric breast pump, sample 
collection procedure and sam ple storage (Appendix D). Participants also 
received four ounce amber glass storage containers with Teflon fitted lids, a 
pumping schedule (Appendix E) for the first month coiiection period and their
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personal use breast pump.
The second visit occurred at four weeks postpartum. Participants 
surrendered the first month’s samples, received additional four ounce amber 
glass storage containers, met with the researchers to answer any questions and 
set up a pumping schedule for the second month collection period. During the 
second visit, participants were asked to complete an environmental survey on 
their own and mail back to UNH in a self-addressed stamped envelope or return 
it to the researchers at the third visit.
The third visit occurred at eight weeks postpartum. Participants 
surrendered the second month’s samples, provided the completed environmental 
survey, received additional four ounce amber glass storage containers, met with 
the researchers to answer any questions and set up the final pumping schedule 
for the third month collection period. The fourth visit occurred at 12 weeks 
postpartum, when participants surrendered the third month’s samples, had their 
body weight measured, completed a food frequency questionnaire and received 
study debriefing.
The first seventeen participants were asked for a maximum of nine breast 
milk samples during the first three-months of breastfeeding. Each participant 
provided up to three samples at the end of their first, second, and third month of 
breastfeeding for evaluation of day-to-day and month-to-month variation in PBDE 
levels. To evaluate day-to-day variation in PBDE levels, participants provided 
one sample from three successive mornings at the end of months one, two and
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three. Day-to-day variation was analyzed on the first five participants. Month-to- 
month variation in PBDE levels was evaluated on ail participants by taking one 
sample at the end of months one, two, and three. The first day sample was 
taken for month-to-month variation from those participants who provided three 
samples per month.
Breast Milk Expression and Collection
Participants used the Ameda Purely Yours® personal use electric breast 
pump to collect their samples. One sample was the equivalent of one complete 
expression from one breast. The collected volume of breast milk samples 
differed from participant to participant based upon the mother’s milk supply. An 
emphasis was placed on collecting a complete expression to ensure that hind 
milk was included in the sample, which enabled us to examine lactation-specific 
maternal characteristics (e.g. percent lipid content in breast milk) on whoie- 
weight PBDE levels in breast milk Participants were instructed to wash their 
hands and breast with a mild, detergent-free soap prior to milk collection 
(Appendix D). in addition, milk expression occurred between the hours of 6 a.m. 
and 9 a.m. on the determined collection day with a minimum two hour time frame 
since the previous feeding from that breast; this protocol standardized the 
sample coiiection period to reflect the daily average lipid concentration in breast 
milk. Once milk expression was compieted, participants were instructed to 
detach the kit coiiection container from the pump and gently invert the sample 
three to four times and transfer the milk into a labeled study container, which was 
the four ounce amber glass storage container that had been detergent-washed
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and then rinsed with analytical grade solvents in the laboratory (toluene followed 
by hexane). Participants completed the label (Appendix F), which included 
subject number, time of last feeding as well as date and time of milk collection 
and then placed the sample into the refrigerator.
Breast Milk Sample Handling and Storage
Samples were either picked up by the researchers or transported by the 
participants to UNH within 72 hours of expression. Samples were transported in 
a cooler with cooler packs or on ice to keep the samples cold. Upon arrival to 
UNH, the volume was measured and logged into a participant inventory 
spreadsheet (Appendix G), each sample was gently inverted three to four times, 
and an aliquot was transferred into a two ounce amber glass jar with a Teflon 
fitted lid. Ail samples were placed into the freezer (-20° C) until shipment.
Frozen samples were shipped on three separate occasions. Each two 
ounce amber glass jar was wrapped in a plastic storage bag and placed in their 
original boxes. Boxes were placed in a Styrofoam shipping cooler, packed with 
dry ice, and shipped overnight to Dr. Janice K. Huwe’s Biosciences Research 
Laboratory of the U.S. Department of Agriculture in Fargo, North Dakota. Upon 
arrival, samples were placed in the freezer (-65° C) until analysis.
Breast Milk Sample Anaivsis
Analysis of each breast milk sample was performed using previously 
published methodology (Huwe & Smith, 2007; Ryan, 1991; U.S. ERA, 2003). Dr. 
Huwe’s laboratory quantified 46 PBDE congeners in 150 breast milk samples by 
isotope dilution method.
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Sample Preparation. Sample preparation required: 1). extraction of fat 
components and native PBDE analytes from milk samples, 2). determination of 
fat content in milk samples, and 3). cleanup of the samples via column 
chromatography.
Prior to the first step (extraction), a mixture of 10 ^^C-PBDE recovery 
standards (BDE-28, 47, 99,100,153, 154,183,197, 207, and 209) were added 
to each sample; the addition of the recovery standards quantitates precision and 
recovery of the analytical method. Selection of the recovery standards was 
based on the most common congeners that are typically detected in samples and 
standards represented each homolog group (tri, tetra, penta, hexa, hepta, octa, 
nona, and deca). All standards were obtained from either Wellington 
Laboratories (Guelph, Ontario, Canada) or Cambridge isotope Laboratories 
(Andover, MA). The following amounts of each standard were added: 2 ng for 
BDE-28, BDE-47, BDE-99, BDE-100, BDE-153, BDE-154, and BDE-183; 4 ng for 
BDE-197 and BDE-207; and 20 ng for BDE-209 (J.K. Huwe, personal 
communication, July 20, 2007).
The purpose of the first step was to liberate the fat components and native 
PBDE analytes from protein and water soluble substances. This step required 
approximately 2 hours per set of samples. One set of samples was 3 breast milk 
samples from a participant and a method blank or method spike. Each breast 
milk sample (5, 7, or 15 ml) was placed in a Teflon bottle and deproteinated with 
potassium oxalate (20 mg/g milk) (Ryan, 1991). An equal volume of breast milk 
to ethanol was used to disrupt the fat globule membranes. The breast milk-
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ethanol mixture was extracted with an equai volume of diethyl ethenhexane (2:3, 
v:v). Once the layers were separated, the upper organic phases were then 
transferred into large tubes and concentrated on a TurboVap™ concentrator 
(Zymark Corporation, Hopkinton, MA). The remaining solid and aqueous phases 
were extracted with a volume of hexane that was equai to the original aliquot 
volume and centrifuged for 20 minutes. The organic phases were combined with 
any remaining etherhexane and further concentrated to small volumes on the 
TurboVap™: the tube sides were rinsed with hexane while concentrating.
Hexane was added to each concentrate; the diluted concentrate was transferred 
to small Teflon bottles (4 x 10 ml of hexane). The extract was washed with 
distilled water and dried over 20 grams of anhydrous sodium sulfate.
The second step, determining the percent lipid content of the milk samples 
gravimetrically, was done by evaporating and weighing aliquots of the extracted 
samples from step one (10 out of 100 mi). This allows us to report PBDE levels 
on a lipid-adjusted basis, and as needed, on à whole-weight basis. Using the 
lipid-adjusted basis allows for normalizing concentrations of PBDEs both within 
samples from one mother and among samples from many mothers (Needham & 
Wang, 2002). Additionally, these lipid-adjusted concentrations could be used for 
infant intake estimates.
Once the lipid weight was determined for each milk sample, the remaining 
extract was concentrated to 12 ml of hexane, in preparation for the column 
cleanup procedure. Column cleanup is a critical step in sample preparation as it 
separates the lipids and native analytes from other lipid soluble components in
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the milk sample, such as steroids and vitamins (J.K. Huwe, personal 
communication, August 1, 2007).
Each sample was chromatographed on disposable triphasic silica gel and 
basic aiumina oxide columns. These columns were used to remove high 
molecular weight non-polar and polar interferences (U.S. EPA, 2003). Ail 
chromatography was performed using an automated Power Prep instrument 
(Fluid Management Systems, Waltham, MA).
The column chromatography procedure, from the silica column to the 
alumina oxide column to the collection tube, occurred in one uninterrupted 
process over a 2 hour period (J.K. Huwe, personal communication, August 1, 
2007). The PBDEs were eluted from the silica column on to the alumina column 
with hexane. The aiumina column was washed with 2% methylene chloride in 
hexane to remove interfering compounds and then PBDEs were eluted from the 
alumina oxide column to the collection tube in 125 ml of methlylene 
chloride/hexane (50/50) and were reduced in volume on the TurboVap™. The 
small volume (0.2 ml) remaining in the TurboVap™ tube was transferred to an 
amber vial containing dodecane (15 pi) as a keeper solvent and evaporated by a 
steady flow of nitrogen. Three ^^C-PBDE injection standards (BDE-77,139 and 
205) were added to the final volume (20 pi). The following amounts of each 
injection standard were added to the final volume: 1.5 ng for BDE-77 and BDE- 
139, and 3 ng for BDE-205. The injection standards were added prior to high 
resolution gas chromatography (GC) and provided adequate coverage of the 
entire GC elution range; the injection standards quantitated the recovery
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standards by serving as the internai standard.
Sample Anaivsis. Samples were analyzed for PBDEs on a Hewlett 
Packard 5890 GC coupled to a VG Autospec mass spectrometer (Micromass, 
Beveriy, MA). The GC was the analytical instrument for separating the PBDEs. 
Cooi-on-coiumn injection was used to introduce 2 pi of each sample into the GC; 
this injection system was used to minimize thermal degradation of BDE-209. The 
sample underwent instantaneous volatilization and was transported by the carrier 
gas (helium) through the capillary column. Separation of PBDEs was achieved 
on the capillary column using a 30 m DB-5ms column (0.25 mm internal 
diameter, 0.25 pm film thickness) with the temperature programmed from 120°C 
(2 min initial hold) to 300°C at 10°C /min then held for 28 min and the carrier gas 
flow was pressure programmed from 20 psi (2 min initial hold) to 10 psi at 20 
psi/min then to 55 psi at 2 psi/min and held for 15 min (Huwe & Smith, 2007). 
isolated PBDEs eluted from the GC column and were then captured by the mass 
spectrometer.
The mass spectrometer (MS) was run at a resolution of 5000 in the 
selective ion monitoring mode to detect ion pairs (Huwe & Smith, 2007).
Selective ion monitoring was used for its sensitivity with complex samples since 
only the selected masses were detected and plotted. The MS captured the 
isolated PBDEs as they eluted off of the GC column and ionized them into 
electrically charged particles that were transported by an electromagnetic field to 
the mass analyzer. The mass analyzer then sorted the ions according to their 
mass-to-charge ratio. The sorted ions were then detected and the signal was
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sent to the data system where it was recorded in the format of a mass-to-charge 
ratio spectrum (McMaster & McMaster, 1998).
For identification and quantitation of PBDEs, the ratio of the paired ions 
was required to be within 15% of theoretical and the native congener required to 
co-eiute within 1 sec of the ^^C-labeled surrogate or within 4 sec of the 
corresponding standard in the curve when no ^^C-labeled surrogate was present 
(Huwe & Smith, 2007). A six point standard curve was employed to cover the full 
range of PBDE concentrations.
Limit of Detection. The limit of detection (LOD) is the lowest concentration 
of a chemical that can be measured by the analytical method (Needham & Wang,
2002). The LODs for each congener were established from method blanks. A 
method-blank or method spike (precision and recovery check) was run every 
fourth sample. The detection limit was set at three times the standard deviation 
of the blanks; all values below the detection limit were treated as nondetects (nd) 
and were set to zero. Data were blank subtracted because method blanks 
contained detectable amounts of native analytes (J.K. Huwe, personal 
communication, August 1, 2006).
Quaiitv Assurance/Quaiitv Control. The recoveries of all ^^C-surrogates 
were between 25% and 150%; all native congeners were recovery corrected. 
Using spiked samples, the reported native analytes showed recovery and 
precision to be within 20% of the true value. The Huwe laboratory has 
successfully participated in an international inter-lab comparison study conducted 
by the Norwegian Public Health and scored within +/- 30% on breast milk
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analysis of the major PBDEs (J. K. Huwe, personal communication, August 1,
2006).
Laboratory Techniques. Aii glassware was washed by hand with 
detergent and rinsed with tap water, distilled water, and analytical grade solvents 
prior to use. Sample preparation steps were performed in opaque containers.
To minimize exposure to light, samples were either covered or refrigerated 
between steps.
stability study
There were two unfortunate experiences with some of the breast milk 
samples during the research study. The first occurred at UNH when the -20°C 
freezer stopped working at the end of June 2006. The alarm failed to sound and 
the breast milk samples thawed before the problem was noticed. The second 
incidence occurred at Dr. Huwe’s laboratory when a shipment of samples was 
accidentally left in the shipping box on dry ice for several days at the beginning of 
March 2007.
There was a surplus of nine breast milk samples that did not experience 
either of these incidents. These nine samples underwent a replicated 
temperature experience (four for the first incident and five for the second) as we 
wanted confirmation that lipid degradation was not accelerated during the thaw. 
Data showed that, on average, there was a 4.4% decrease in the percent lipid 
content of the nine samples, which was indicative of negligible changes. Dr. 
Huwe then analyzed the PBDE concentrations of three samples (one sample 
from incident #1 and two samples from incident #2). The average percent
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change of the sum of the measured PBDE levels in the three samples was a 
15% increase. The congener profiles for the three samples were further 
examined for differences in their levels; the percent change for the 4 major 
congeners that represented 73% of the total sum included: a 13% increase in 
BDE-47, a 17% increase in BDE-153, a 22% increase in BDE-99, and a 38% 
increase in BDE-100. The stability data is presented in Appendix H. Based on 
the stability experiment, it was concluded that the temperature incidents had a 
minimal effect on the lipid content and PBDE concentrations in breast milk. 
survey development and administration 
A total of four surveys were compieted by the participants during their 
three-month commitment in the study: A Maternal Characteristics Survey, two 
Food Frequency Questionnaires, and a Maternal Environment Survey.
Maternal Characteristics Survey
i administered the Maternal Characteristics Survey during visit one 
(Appendix I). The intent of this survey was to examine potential relationships 
between PBDE levels in breast milk and personal characteristics such as 
demographics, measured body weight, calculated body mass index (BMI), 
breastfeeding history, physical activity level, health history and smoking status. 
During the development phase of the Maternal Characteristics Survey, feedback 
was obtained from academic scholars whose expertise was in epidemiology and 
sociology. Suggestions focused on wording of survey questions to ensure 
readability and clarity. It was also recommended that we collect demographic 
information, particularly on education and income. This would permit our
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findings to be compared to statewide data from the New Hampshire Department 
of Health and Human Services (2002).
Food Frequency Questionnaire
The Food Frequency Questionnaire was administered twice during the 
study, as pregnancy and the postpartum period can cause changes in dietary 
behavior (Devine et ai., 2000; George et al., 2005). Nutrient data was collected 
using a food frequency questionnaire developed by the Nutrition Assessment. 
Shared Resource (NASR) of Fred Hutchinson Cancer Research Center 
(FHCRC) (Patterson et ai., 1999) (Appendix J). Dietary intake during the iast 
trimester of pregnancy was evaluated at visit one, and dietary intake during the 
three-month postpartum period was evaluated at visit four. I assisted participants 
in completing the questionnaire by asking each question and filling out the form 
while the participant foliowed along with their own copy. I explained the format of 
the questionnaire and used food models to assist participants with estimating 
portion sizes. All completed food frequency questionnaires were sent to FHCRC 
for a comprehensive analysis of 125 nutrients.
The nutrient data that was extracted from the FHCRC analysis included 
the following: total calories; grams of carbohydrate, total fiber, water-soluble 
fiber, insoluble fiber, protein, vegetable protein, animal protein, total fat, saturated 
fat, polyunsaturated fat, monounsaturated fat, trans-tatty acids, and alcohol; and 
milligrams of cholesterol. In addition, 27 questions were selected to quantify the 
frequency and amount of meat, fish, egg, dairy product, fruit, vegetable, and 
fat/oil consumption.
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Maternal Environment Survey
A Maternal Environment Survey was completed by each participant on 
their own time in their home (Appendix K). The intent of the Maternai 
Environment Survey was to evaluate for associations between PBDE levels in 
breast fniik and living/occupational environment. The survey contained questions 
on residence history, subject occupation, details of transportation mode, 
household appliances, furniture, electronics, and other PBDE-containing 
products. Dr. Tom Webster (personal communication, July 26, 2005) from 
Boston University School of Public Health shared his survey from the Greater 
Boston PBDE Body Burden Project, which assisted in developing the content of 
our Maternal Environment Survey.
A UNH epidemiologist provided guidance during the development phase 
of the Maternal Environment Survey. The primary suggestion was to validate the 
survey, it was beyond the scope of this research to implement sensitivity and 
specificity testing on the survey, but feasible to conduct a piiot-test with a similar 
population of participants to optimize content, readability and range of responses.
The Maternal Environment Survey underwent a pilot-test with women who 
were currently lactating or who had breastfed within the past year. A total of 19 
surveys were distributed to New Hampshire women during the fall of 2005. 
Women were asked to complete the Environment Survey in their home, and fill 
out a feedback questionnaire (Appendix L). Out of 19 surveys, 16 (84%) surveys 
were completed and returned. Range of responses was reviewed on all 
completed surveys. This provided valuable insight on the readability, clarity and
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interpretation of survey questions. Completed surveys were evaluated for 
missing data and if information was filled out correctly. A wide range of 
responses for one question on stereo equipment led us to re-word this question 
for improved clarity.
in addition to filling out the survey for the piiot-test, women completed a 
feedback questionnaire in which additional comments on survey questions, 
length of time to complete the survey and suggestions for improvement were 
recorded. Comments from participants on the feedback questionnaire provided 
additional insight on survey questions that required refinement of language and 
response options. The average length of time to complete the survey was 15 
minutes, and participants agreed that completing the survey in the home was 
helpful. Overall, women found the survey easy to follow with minor suggestions 
for improvement. The preliminary work for the Maternal Environment Survey 
provided valuable feedback, and the necessary changes were implemented prior 
to recruitment.
statistical anaivsis
PBDE data was log-transformed prior to statistical analyses, and normality 
of PBDE concentrations was assessed using normal probability plots and 
Shapiro-Wiik’s test. PBDE concentrations in breast milk (monthly means and 
three-month means) were evaluated for associations with dietary habits (last 
trimester and postpartum), maternal characteristics, and living/occupational 
environments. Potential associations were explored using scatter plots, 
correlation analysis, and backward regression. Differences in dietary intake from
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the last trimester and three-month postpartum period were evaluated using 
paired samples t-test. Differences in mean PBDE values over time and mean 
percent lipid levels from months one, two, and three were evaluated using 
repeated-measures analysis of variance. Regression analysis was used to 
evaluate the relationship between PBDE levels in breast milk and maternal 
characteristics, living/occupational environments, and dietary intake. Potential 
confounders were evaluated for associations with exposure variables, and by 
examining the changes in the |3 coefficients when excluded variables were added 
back into the reduced model. If the addition of the excluded variable caused a 
change in the (3 coefficient by at least 10%, the variable remained in the model 
(Friis & Sellers, 2004; Sjodin et al., 2008). Regression coefficients were 
converted back to the original scale, which provides the fold change (or percent 
increase or decrease) in breast milk PBDE concentrations per unit of exposure. 
Statistical analyses were performed using the Statistical Package for Social 
Science (SPSS) 13.0 version with statistical significance set at 0.05.
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CHAPTER IV
MANUSCRIPT 1: BIOMONITORING BREAST MILK POLYBROMINATED 
DIPHENYL ETHERS AS A FUNCTION OF ENVIRONMENT, DIETARY INTAKE, 
AND DEMOGRAPHICS OF LACTATING WOMEN IN THE SEACOAST AREA
OF NEW HAMPSHIRE
introduction
Biological monitoring, or biomonitoring is the measurement of 
environmental chemicals, their metabolites, or their reaction products in the 
human body, specifically through blood, urine, saliva, breast milk, adipose or 
other tissue (Needham et al., 2007; U.S. DHHS, CDC, 2005). The purpose of 
biomonitoring is to document, update and expand human exposure information 
on environmental chemicals. The use of breast milk as a biological matrix for 
biomonitoring studies can estimate environmental chemical exposure in both the 
mother and breast feeding infant (Lovelady et al., 2002). Breast milk can be a 
convenient and noninvasive means for estimating environmental chemical 
exposures in nursing women as compared to other biological matrices (Hooper & 
She, 2003); it also enables researchers to collect a biological specimen with a 
high fat content (Fenton etal., 2005), which is an important consideration for 
lipid-soluble environmental chemicals -  particularly those that have been steadily 
rising in their production, use, and presence in the environment and in humans, 
such as synthetic flame retardants.
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Flame retardants are added to materials either during or after 
manufacturing, in order to interfere with the combustion process (Bromine 
Science and Environmentai Forum [BSEF], 2000). This interference can occur 
during heating, decomposition, ignition or flame spread. Of the four major 
classes of flame retardants - halogenated organic (usually brominated or 
chlorinated), phosphorus-containing, nitrogen-containing, and inorganic flame 
retardants, the brominated flame retardants (BFRs) are the most widely used due 
to their low cost and high performance efficiency. (Birnbaum & Staskal, 2004; 
BSEF, 2000). The most widely used BFRs are tetrabromobisphenol A, 
hexabromo-cyclododecane, and three commercial products of polybrominated 
diphenyl ethers (PBDEs) known as decabromodiphenyl ether (decaBDE), 
octabromodiphenyl ether (octaBDE) and pentabromodiphenyl ether (pentaBDE) 
(Birnbaum & Staskal, 2004; BSEF, 2000). The total U.S. market demand values 
for pentaBDE and octaBDE are expected to drop to zero because Great Lakes 
Chemical Corporation, the sole U.S. manufacturer of pentaBDE and octaBDE, 
discontinued production of these two commercial products at the end of 2004 
(U.S. EPA, 2006).
PBDEs are non-chemically bound additives, and may contribute up to 
30% by weight of foams, fabrics and plastics (Hale et al., 2003; Hooper & She,
2003). Overtime, PBDEs can diffuse out of their products, become airborne or 
enter dust, and disperse into the environment and into humans. Even though the 
presence of PBDEs in consumer products such as teievision sets, carpet 
padding, mattresses, chair and couch foams, computers, stereos, and hair dryers
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saves lives each year in the U.S., there are concerns with its widespread use and 
increasing environmental and human concentrations. Their persistent, iipid- 
solubie characteristics permit PBDEs to bioaccumuiate as they are released from 
consumer products into the air through normal use, degradation, disposal, and 
recycling. Additionai release can also occur during PBDE manufacturing and 
incorporation into products (Hale et al., 2003).
Biomonitoring PBDEs through breast milk has enabled researchers to 
document levels worldwide (Akutsu et ai., 2003; Bi et ai., 2006; Chao et al., 2007; 
ErdogruI et al., 2004; Esiami et al., 2006; Fângstrôm et al., 2005; Gômara et al., 
2007; ingeiido et al., 2007; Jaraczewska et al., 2006; Kalantzi et al., 2004; Kazda 
et al., 2004; Lind et al., 2003; Main et al., 2007; Meironyté et al., 1999; Norén & 
Meironyté, 2000; Ohta et al., 2002; Ryan & Patry, 2000; Ryan et al., 2006; 
Schuhmacher et al., 2007) and in the U.S. (Hooper et ai., 2007; Johnson- 
Restrepo et al., 2007; Lunder & Sharp, 2003; Schecter et al., 2005; Schecter et 
ai., 2003; She et ai., 2007; Wu et al., 2007). One study in the U.S. has reported 
rates of PBDE eiimination in a smail sampie of nursing mothers from California 
(Hooper et ai., 2007). Additionaiiy, breast milk biomonitoring studies provide 
information about sources of PBDE exposure.
in the U.S. a iimited number of studies have demonstrated relationships 
between PBDE levels in breast miik and house dust, dairy intake, and meat 
intake (Wu et al., 2007). There is a need to further document PBDE ievels in 
humans, examine PBDE ieveis in breast milk overtime, and further evaluate 
potential sources of PBDE exposure.
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The goal of this research was to determine the ieveis of PBDEs in breast 
milk of lactating women from the Seacoast region of New Hampshire and to 
examine potential relationships between breast miik PBDE levels and stage of 
lactation, maternai characteristics, living environment and dietary intake.
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materials & methods
Participants were recruited from the Seacoast region of New Hampshire 
from November 2005 to July 2006. Recruitment was accomplished by lactation 
consultants from three area hospitals, distribution of a communication pamphlet, 
and word of mouth. Women, ages to 22 to 40 from the Seacoast region of New 
Hampshire, who were in the early stages of lactation (less than 2 weeks) or in 
their last trimester of pregnancy and planned to breastfeed for at least the first 
three-months postpartum, were eligible for the study. Participant eligibility criteria 
also included delivering a full-term, healthy infant and planning to provide greater 
than 80% of breast milk as the primary source of nutrition for the first three- 
months. The study protocol was approved by the University of New Hampshire 
(UNH) Institutional Review Board (IRB # 3433) and approval from each hospital 
was obtained prior to working with the lactation consultants. All participants 
provided informed consent prior to their enrollment into the study.
Studv Design
Participants were asked to visit with researchers on four occasions over a 
three-month period for a total of approximately four hours (Figure 1 ).
Researchers could meet with participants in their homes or at UNH. To show our 
appreciation for participation in the study, enrolled subjects were provided with 
an Ameda Purely Yours® personal use electric breast pump and kit. Participants 
had the opportunity to talk with a professional lactation consultant during their 
enrollment in the study.
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Visit 1 : Study orientation, obtained consent, administered Maternal Characteristics Survey & Food Frequency 
Questionnaire #1, measured body weight, provided personal use electric breast pump and kit
Visit 2: Sample pick-up (1 or 3 samples), provided Environment Survey
Visit 3: Sample pick-up (1 or 3 samples), retrieved Environment Survey
Visit 4: Sample pick-up (1 or 3 sarrples), administered Food Frequency Questionnaire #2, measured body weight,
study debriefing
Figure 1. Study design from recruitment to visit 4.
Survevs
A total of four surveys were completed by the participants during their 
three-month commitment in the study: A Maternal Characteristics Survey, two 
Food Frequency Questionnaires, and a Maternal Environment Survey. All 
participants were interviewed in person for each survey with the exception of the 
Maternal Environment Survey. The Maternal Characteristics Survey examined 
potential relationships between PBDE levels in breast milk and personal 
characteristics such as demographics, measured body weight, calculated body
65
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
mass index (BMI), breastfeeding history, physical activity level, health history and 
smoking status.
The Food Frequency Questionnaire, developed by the Nutrition 
Assessment Shared Resource (NASR) of Fred Hutchinson Cancer Research 
Center (FHCRC) (Patterson et al., 1999) was administered twice during the 
study -  at the beginning to assess dietary intake during the last trimester and at 
the end to assess dietary intake during the first three-months postpartum. The 
two time periods were assessed as pregnancy and the postpartum period can 
cause changes in dietary behavior (Devine et al., 2000; George et al., 2005). We 
worked with participants by completing the questionnaire with them on both 
occasions, and showed food models to assist in estimating portion sizes. All 
completed food frequency questionnaires were sent to FHCRC for a 
comprehensive analysis of 125 nutrients. The nutrient data that was extracted 
from the FHCRC analysis included the following: total calories; grams of 
carbohydrate, total fiber, water-soluble fiber, insoluble fiber, protein, vegetable 
protein, animal protein, total fat, saturated fat, polyunsaturated fat, 
monounsaturated fat, frans-fatty acids, and alcohol; and milligrams of cholesterol. 
In addition, 27 questions were selected to quantify the frequency and amount of 
meat, fish, egg, dairy product, fruit, vegetable, and fat/oil consumption.
The Maternal Environment Survey evaluated associations between PBDE 
levels in breast milk and living/occupational environment. The survey contained 
questions on residence history, subject occupation, details of transportation 
mode, household appliances, furniture, electronics, and other PBDE-containing
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products. Prior to recruitment, the Maternal Environment Survey underwent a 
pilot-test with a similar population of participants to optimize content, readability 
and range of responses.
Breast Milk Sampling
The first seventeen participants were asked for a maximum of nine breast 
milk samples during the first three-months of breastfeeding. To evaluate day-to- 
day variation in PBDE levels, participants provided one sample from three 
successive mornings at the end of months one, two, and three. Day-to-day 
variation was analyzed on the first five participants. Month-to-month variation in 
PBDE levels was evaluated on all participants by taking one sample at the end of 
months one, two, and three. The first day sample was taken for month-to-month 
variation from those participants who provided three samples per month.
Participants used the Ameda Purely Yours® personal use electric breast 
pump to collect their samples. One sample was the equivalent of one complete 
expression from one breast. The collected volume of breast milk samples 
differed from participant to participant based upon the mother’s milk supply. An 
emphasis was placed on collecting a complete expression to ensure that hind 
milk was included in the sample, which enabled us to examine lactation-specific 
maternal characteristics (e.g. percent lipid content in breast milk) on whole- 
weight PBDE levels in breast milk. In addition, milk expression occurred 
between the hours of 6 a.m. and 9 a.m. on the determined collection day with a 
minimum two hour time frame since the previous feeding from that breast; this 
protocol standardized the sample collection period to reflect the daily average
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lipid concentration in breast milk. Once milk expression was completed, 
participants were instructed to detach the kit collection container from the pump 
and gently invert the sample three to four times and transfer the milk into a 
labeled study container, which was a four ounce amber glass storage container 
that had been detergent-washed and then rinsed with analytical grade solvents 
(toluene followed by hexane). Participants labeled the amber glass storage 
container and placed the sample into the refrigerator.
Samples were either picked up by the researchers or transported to UNH 
within 72 hours of expression. Samples were transported in a cooler with cooler 
packs or on ice to keep the samples cold. Upon arrival to UNH, the volume was 
measured, each sample was gently inverted three to four times, and an aliquot 
was transferred into a two ounce amber glass jar with a Teflon fitted lid. All 
samples were placed into the freezer (-20° C) until shipment.
Analvtical Methods
Frozen samples were shipped overnight to the Biosciences Research 
Laboratory of the U.S. Department of Agriculture in Fargo, North Dakota. Upon 
arrival, samples were placed in the freezer (-65° C) until analysis. Analysis of 
each breast milk sample was performed using previously published methodology 
(Huwe & Smith, 2007; Ryan, 1991; U.S. ERA, 2003). Forty-six PBDE congeners 
in 150 breast milk samples were measured by isotope dilution method.
Prior to extraction, a mixture of 10 ^^C-PBDE recovery standards (BDE-28, 
47, 99,100, 153,154,183, 197, 207, and 209) were added to each sample. All 
standards were obtained from either Wellington Laboratories (Guelph, Ontario,
68
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Canada) or Cambridge Isotope Laboratories (Andover, MA). Each breast milk 
sample (5, 7, or 15 ml) was deproteinated with potassium oxalate (20 mg/g milk). 
An equal volume of breast milk to ethanol was used to disrupt the fat globule 
membranes. The breast milk-ethanol mixture was extracted with an equal 
volume of diethyl ether:hexane (2:3, v:v). Once the layers were separated, the 
upper organic phases were then transferred into large tubes and concentrated on 
a TurboVap™ concentrator (Zymark Corporation, Hopkinton, MA). The final 
extract was washed with distilled water and dried over 20 grams of anhydrous 
sodium sulfate. After solvent evaporation, the lipid content of the milk samples 
was determined gravimetrically. Once the lipid weight was determined for each 
milk sample, the remaining extract was concentrated to 12 ml of hexane, in 
preparation for the column cleanup procedure.
Each sample was chromatographed on disposable triphasic silica gel and 
basic alumina oxide columns. All chromatography was performed using an 
automated Power Prep instrument (Fluid Management Systems, Waltham, MA). 
The final volume (0.2 ml) was transferred to an amber vial containing dodecane 
(15 pi) as a keeper solvent and evaporated by a steady flow of nitrogen. Three 
^^C-PBDE injection standards (BDE-77,139 and 205) were added to the final 
volume (20 pi) prior to high resolution gas chromatography (GC).
Samples were analyzed for PBDEs on a Hewlett Packard 5890 GC 
coupled to a VG Autospec mass spectrometer (Micromass, Beverly, MA). Cool- 
on-column injection was used to introduce 2 pi of each sample into the GC. 
Separation of PBDEs was achieved on the capillary column using a 30 m DB-
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Sms column (0.25 mm internal diameter, 0.25 pm film thickness) with the 
temperature programmed from 120°C (2 min initial hold) to 300“C at 10°C /min 
then held for 28 min and the carrier gas flow was pressure programmed from 20 
psi (2 min initial hold) to 10 psi at 20 psi/min then to 55 psi at 2 psi/min and held 
for 15 min. Isolated PBDEs eluted from the GC column and were then captured 
by the mass spectrometer. The mass spectrometer (MS) was run at a resolution 
of 5000 in the selective ion monitoring mode to detect ion pairs (Huwe & Smith,
2007).
For identification and quantitation of PBDEs, the ratio of the paired ions 
was required to be within 15% of theoretical and the native congener required to 
co-elute within 1 sec of the ^ ^C-labeled surrogate or within 4 sec of the 
corresponding standard in the curve when no ^^C-labeled surrogate was present 
(Huwe & Smith, 2007). A six point standard curve was employed to cover the full 
range of PBDE concentrations.
The limit of detection (LCD) for each congener was established from 
method blanks. A method blank or method spike (precision and recovery check) 
was run every fourth sample. The detection limit was set at three times the 
standard deviation of the blanks; all values below the detection limit were treated 
as non-detects (nd) and were set to zero. Data were blank subtracted because
method blanks contained detectable amounts of native analytes (J.K. Huwe,
/
personal communication, August 1, 2006).
The recoveries of all ^^C-surrogates were between 25% and 150%; all 
native congeners were recovery corrected. Using spiked samples, the reported
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native analytes showed recovery and precision to be within 20% of the true 
value. The Huwe laboratory has successfully participated in an international 
inter-lab comparison study conducted by the Norwegian Public Health and 
scored within +/- 30% on breast milk analysis of the major PBDEs (J. K. Huwe, 
personal communication, August 1, 2006).
All glassware was washed by hand with detergent and rinsed with tap 
water, distilled water, and analytical grade solvents prior to use. Sample 
preparation steps were performed in opaque containers. To minimize exposure 
to light, samples were either covered or refrigerated between steps.
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Statistical Analysis
PBDE data was log-transformed prior to statistical analyses, and normality 
of PBDE concentrations was assessed using normal probability plots and 
Shapiro-Wilk’s test. PBDE concentrations in breast milk (monthly means and 
three-month means) were evaluated for associations with dietary habits (last 
trimester and postpartum), maternal characteristics, and living/occupational 
environments. Potential associations were explored using scatter plots, 
correlation analysis, and backward regression. Differences in dietary intake from 
the last trimester and three-month postpartum period were evaluated using 
paired samples t-test. Differences in mean PBDE values over time and mean 
percent lipid levels from months one, two, and three were evaluated using 
repeated-measures analysis of variance. Regression analysis was used to 
evaluate the relationship between PBDE levels in breast milk and maternal 
characteristics, living/occupational environments, and dietary intake. Potential 
confounders were evaluated for associations with exposure variables, and by 
examining the changes in the‘(3 coefficients when excluded variables were added 
back into the reduced model. If the addition of the excluded variable caused a 
change in the (3 coefficient by at least 10%, the variable remained in the model 
(Friis & Sellers, 2004; Sjodin et al., 2008). Regression coefficients were 
converted back to the original scale, which provides the fold change (or percent 
increase or decrease) in breast milk PBDE concentrations per unit of exposure. 
Statistical analyses were performed using the Statistical Package for Social 
Science (SPSS) 13.0 version with statistical significance set at 0.05.
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results
Demographic Characteristics of Participants
A total of 63 women expressed an interest in the study; however, only 42 
women were eligible. Two of the 42 women were unable to participant due to 
limited milk supply at the start of the study. A total of 40 women completed the 
study with an average age of 31 years (range 22 to 40). Participants’ current 
residential locations represented 16 different towns from the Seacoast area of 
New Hampshire (Figure 2). The highest percentage (25%) of participants 
resided in Dover, New Hampshire.
Note. Town locations on the map are: Milton (1 ). Somersworth (2). Rochester (3), Rolllnsfbrd (4), Dover (5). Barrington (6). 
Nottingham (7). Madbury (8), Lee (9), Newmaricet{10), Epping (11), Exeter (12). Stratham (13), Hampton Falls (14), Seabrook 
(15), Portsmouth (16). *
Figure 2. Breast milk sampling locations in New Hampshire
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There was limited diversity among participants: thirty-nine out of 40 participants 
were Caucasian, and 80% of participants had completed a 4-year college degree 
or higher (Table 1).
Each participant visited with researchers on four occasions over a three- 
month period for a total of 160 visits. Participants were provided with the option 
to conduct visits in their homes or at UNH: a total of 153 visits (96%) were 
conducted at participant homes and 7 visits were at UNH.
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Table 1.
Participant characteristics of study population
Characteristics n = 40
Maternal age, years (mean, SD)
Calculated BMI (kg/m^), start® (mean, SD)




Level of Education (%)
Less than high school graduate 
High school diploma or GED 
Some college or technical school 
College graduate, 2-year degree 
College graduate, 4-year degree 
Masters degree 
Doctoral degree
Total Household Income (%)
Less than $20,000 
$20,000 to $34,999 







First time mothers (%)
Parity (years)
Exclusively breast feeding, start” (%)


























range 22 to 40 
range 20.8 to 35.9 
range 19.2 to 36.6
Note. ® Weight measured at the start of the study which was at 2 to 3 weeks postpartum; ° Weight 
measured at the end of the study which was at 12 weeks postpartum; ” Start was 2 to 3 weeks 
postpartum; * End was 12 weeks postpartum; ® One vegan and 4 semi-vegetarians (2 excluded 
red meat; 2 excluded red meat and poultry).
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PBDE Levels in Breast Milk
PBDE levels were reported with non-detects = zero. BDE-209 levels were 
widely variable due to background contamination as detected In method blanks. 
The detection limit range for BDE-209 was 2.2 to 38.4 ng/g lipid (mean = 12 +/- 9 
ng/g llpid). Therefore, BDE-209 was not Included In the sum of PBDEs 
(XPBDE). The ^PBDE congeners found In breast milk was defined as: BDE- 
28/33,47, 85, 99, 10^, 153, 154, and 183. BDE-47 was the predominant 
congener for each month and correlated with ^PBDEs (r = 0.78 p < 0.001 ). The 
contribution of BDE-47 to ^PBDEs Increased as the sum Increased (Figure 3a). 
BDE-47 was correlated with BDE-28/33, BDE-85, BDE-99, BDE-100, and BDE- 
154; however, BDE-47 was not correlated with BDE-153 and BDE-183 (Table 2). 
BDE-153 was correlated with ^PBDEs (r= 0.66 p < 0.001) and BDE-100; the 
contribution of BDE-153 to the ^PBDEs Increased as the sum Increased (Figure 
3b). Log-transformed XPBDEs, BDE-47, and BDE-153 levels were evaluated 
over time (stage of lactation) and for associations with maternal characteristics, 
dietary habits, and llvlng/occupatlonal environments.
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(a)







natural log sum PBDE 3-month participant means (ng/g iipid)






i 3.00 4.00 5.002.00
natural log sum PBDE 3-month participant means (ng/g lipid)
Figures 3a and 3b: Correlations between breast milk concentrations of the 
ZPBDE and BDE-47 (a) and BDE-153 (b)
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stage of Lactation and Sum of PBDEs: There was no significant 
difference in mean ZPBDE levels from months one, two, and three, which was a 
similar finding to other research (Table 3) (Hooper et al., 2007), thus confirming 
that PBDE levels in breast milk are stable for the first three-months postpartum. 
The relationship between ^PBDE levels and time did not change based on age, 
BMI, or number of other prior children breastfed. The ^PBDE concentrations in 
breast milk over the three-month collection period ranged from 6.5 to 166.7 ng/g 
lipid. The mean for the three-month period was 35.5 ng/g with a median value of 
29.7 ng/g lipid.
Table 3.











Month 1 6.8 166.7 37.3® 28.6
Month 2 6.6 133.7 35.1® 28.1
Month 3 6.5 118.4 34.1® 32.8
Note. ® No significant differences between months 1, 2, and 3 means.
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Day-to-day variation in PBDE levais was analyzed on the first five 
participants (Figure 4). A total of 45 breast milk samples (9 samples per 
participant) were analyzed. The variation from day-to-day revealed that 41 out of 
45 samples had less than a 20% change in the ^PBDE concentrations from day 
one to day two, day two to day three, and day one to day three. The largest 
variation occurred in only 2 of the 5 samples during month two, day two where 
the percent change was greater than 40%. Because methodological variation 
was 20% (J.K. Huwe, personal communication, June 23, 2006), it was concluded 
that day-to-day variation was minimal. From this point forward, it was decided to 
only collect and analyze one sample per month from each participant.
 Day 1






Figure 4. Mean day-to-day variation for months one, two, and three.
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stage of Lactation and Congeners. The median congener pattern of 
breast milk samples from month one was 47% BDE-47, 17% BDE-153, 9% BDE- 
100, 8% BDE-99, and 19% other congeners. The average congener pattern 
from month two was 44% BDE-47, 15% BDE-153, 9% BDE-99, 7% BDE-100, 
and 25% other congeners. Lastly, the average congener pattern from month 
three was 38% BDE-47, 14% BDE-153, 8% BDE-99, 6% BDE-100, and 34% 
other congeners. There were no significant differences in mean BDE-47, BDE- 
153, or BDE-100 levels from months one, two, and three. The relationship 
between the congener ievels and time did not change based on age, BMI, or 
number of other prior children breastfed.
BDE-47 was the predominant congener in 80% of the samples, which is 
similar to previously reported studies. However, BDE-153 was the predominant 
congener in 20% of the participants’ samples from each month. It was also 
noted that the median BDE-153 contribution to the ^PBDEs was higher as 
compared to some of the previously reported breast milk biomonitoring studies in 
the U.S. (15% vs. 5 to 10% of %^PBDEs) (Johnson-Restrepo et al., 2007; 
Schecter et al., 2003; She et al., 2007; Wu et al., 2007). A comparison of the 
PBDE congener profiles from month-to-month is displayed in Figure 5, and 
congener levels are provided in Table 4; PBDE levels in individual breast milk 
samples from each month are reported in Appendix H.
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16 1
a  Month 1 
m Month 2 
□ Month 3
BDE-28/33 BDE-47 BDE-100 BDE-99 BDE-154 BDE-85 BDE-153 BDE-183 
PBDE Congeners (median levels)
Figure 5. Comparison of PBDE congener patterns in breast milk samples 
(n = 40, median levels).
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Table 4.













BDE-28 & 33 1.5 0.3 5.4 100 (0.06)
BDE-47 13.4 3.7 59.0 100 (0.83)
BDE-85 0.2 < DL 0.8 65 (0.03)
BDE-99 2.4 < DL 6.6 90 (0.65)
BDE-100 2.5 0.4 15.3 100 (0.16)
BDE-153 4.9 0.8 109.6 100 (0.08)
BDE-154 0.1 < DL 0.5 78 (0.07)
BDE-183 <DL <DL 2.3 33 (0.16)
Month 2
BDE-28 & 33 1.4 0.4 4.7 100
BDE-47 12.4 3.9 54.1 100
BDE-85 0.2 <DL 2.1 65
BDE-99 2.4 < DL 7.3 88
BDE-100 2.1 0.4 15.7 100
BDE-153 4.3 1.0 83.8 100
BDE-154 0.1 < DL 0.7 73
BDE-183 <DL < DL 1.3 30
Month 3
BDE-28 & 33 1.3 0.3 4.3 100
BDE-47 12.6 3.8 43.5 100
BDE-85 0.2 <DL 1.4 55
BDE-99 2.5 <DL 10.2 88
BDE-100 2.1 0.4 12.0 100
BDE-153 4.7 0.8 81.3 100
BDE-154 0.2 <DL 0.5 63
BDE-183 <DL <DL 0.9 33
Note. < DL = below the detection limit; ®the average DL values over the sample analysis time 
frame in ng/g lipid.
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PBDE Levels in Breast Milk and Maternal Characteristics
Percent Lipid. The mean lipid content in breast milk for month one was 
3.3% (range 1.6 to 5.0%), for month two was 3.3% (range 1.1 to 8.5%), and for 
month three was 3.0% (range 0.9 to 6.8%). There was no significant difference 
in mean percent lipid values from months one, two, and three. There was a 
significant, positive association between XPBDE levels (ng/g milk) and percent 
lipid content in breast milk samples over the three-month period (r= 0.62 p < 
0.001) (Figure 6) with a similar Spearman’s correlation coefficient (r= 0.64 p < 
0.001). The significant, positive observation validates reporting PBDE levels on 
a lipid-adjusted basis.
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Percent iipid content in breast milk
Figure 6. The association between ^PBDE levels (ng/g milk) and percent lipid 
content in breast milk.
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Maternal Characteristics Survey. Some of the data from the Maternal 
Characteristics survey indicated limited variability among participants, including 
education, ethnicity, total household income, and health history information.
There were no associations between ^PBDE levels and age, parity, body mass 
index, pre-pregnancy weight, number of other children breastfed, physical activity 
level, weight lost on a diet, vegetarian status, smoking history, or the estimated 
amount of supplementary formula provided to the infant during the study. Similar 
findings were also seen with congener (BDE-47 and BDE-153) levels and 
maternal characteristics, however, an association was seen between BDE-153 
and age (r = 0.36 p = 0.02, participant three-month means). For each unit (year) 
increase in age, there was a 1.1- fold change (or 10% increase) in BDE-153 
(Figure 7). The association between age and BDE-153 weakened after adjusting 
for change in BMI from the start of the study until the end (r = 0.36 p = 0.07). 
Change in BMI was included as a confounding variable based upon its 
association with age and its effect on the p coefficient (Table 5).
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r = 0.36 p = 0.02
2-
g -2“
2520 30 35 40
Age, years (start o f study)
Figure 7. The association between BDE-153 levels in breast milk and age.
Table 5,
The effect of confounding on age
Age (Exposure)
Confounder Spearman’s Correlation Coefficient Adjusted p
(p value) (95% Cl)
Change in BMI from 0.45 1.2®
start of study to end (p = 0.004) (1.0,1.2)
Hote. Crude (3 was 1.1 (95% Cl = 1 .0 -  1.2).
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PBDE Levels in Breast Milk and Dietary Intake
The transition from the last trimester of pregnancy to the three-month 
postpartum period was associated with decreases in mean caloric intakes (2,349 
vs. 1,930 calories, p < 0.001 ) as well as decreases in major nutrients of interest, 
such as grams of carbohydrate (333 vs. 261 grams, p < 0.001), grams of fat (84 
vs. 71 grams, p < 0.012), and grams of protein (85 vs. 71 grams, p < 0.001). 
However, out of the 25 questions selected to quantify meat, fish, egg, dairy 
product, and fat/oil consumption, only 5 of those questions differed significantly 
from the last trimester to the three-month postpartum period including: low fat hot 
dog and sausage consumption (0.6 vs. 3 total servings over three-months, p < 
0.031): lean lunch meat consumption (14 vs. 22 total servings over three-months, 
p < 0.049); ground meat consumption (16 vs. 12 total servings over three- 
months, p < 0.016); butter/margarine and other fat consumption on starches and 
vegetables (44 vs. 23 total servings over three-months, p < 0.009); and milk 
consumption (104 vs. 62 total servings over three-months, p < 0.004).
There were no significant associations between PBDE levels (X, BDE-47, 
and BDE-153) and the majority of nutrients consumed during the last trimester or 
three-month postpartum period. However, there was a small, but significant 
association between BDE-153 and saturated fat consumption during the three- 
month postpartum period. For each unit (gram) increase in daily saturated fat 
intake, there was a 1.04-fold change (or 4% increase) in BDE-153 levels 
(monthly means and participant three-month means) (r = 0.31 p = 0.05, 
participant three-month means) (Figure 8). The association between saturated
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fat intake during the postpartum period and BDE-153 persisted after adjusting for 
total meat consumption during the postpartum period (r= 0.41 p = 0.03, 
participant three-month means) (Table 6). Total meat consumption during the 
postpartum period was included as a confounding variable based upon its 
association with saturated fat and its effect on the 3 coefficient (Table 7). There 
was no association between saturated fat consumption and BDE-153 during the 
last trimester.










0 10 20 30 40 SO 60
Average daily intake of saturated fat (grams, postpartum)
Figure 8. The association between BDE-153 levels in breast milk and 
consumption of saturated fat during the three-month postpartum period.
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Table 6.
Association between BDE-153 and saturated fat consumption during the three- 
month postpartum period
Transformed p* p value Adjusted p*" p value'’
BDE-153 and 
saturated fat consumption
1.04 0.05 1.1 0.03
Note. The p coefficients provide the fold change in BDE-153 concentrations in breast miik per 
unit of exposure (grams):  ^Adjusted for totai meat intake in the postpartum period.
Table 7.
The effect of confounding on saturated fat consumption
Saturated Fat Consumption (Exposure)
Confounder Spearman’s Correlation Coefficient Adjusted p
(p value) (95% Cl)
Total meat consumption 0.41 1.1*
during the postpartum period (p = 0.009) (1.0,1.1)
Note. * Crude P was 1.04 (95% Cl = 1.0 -  1.1).
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The frequency of meat, fish, dairy product, egg, fat/oil, and vegetable 
consumption during the last trimester and three-month postpartum period was 
not associated with PBDE levels (X, BDE-47, and BDE-153). However, the 
strongest association between ][PBDE levels and diet was seen with total fruit 
consumption in the last trimester of pregnancy (Figure 9). For each unit (serving) 
increase in fruit, there was a 0.87-fold change (or 13% decrease) in %PBDE 
levels (monthly means and participant three-month means) (r = 0.36 p = 0.02, 
participant three-month means). The association persisted between fruit 
consumption during the last trimester and ][PBDE levels after adjusting for total 
calorie and carbohydrate consumption during the last trimester (r= 0.56 p = 0.02, 
participant three-month means) (Table 8). Calorie and carbohydrate 
consumption during the last trimester were included as confounding variables 
based upon their association with fruit intake and their effect on the p coefficient 
(Table 9). Similar findings were also seen with BDE-47 and fruit consumption in 
the last trimester (monthly means and participant three-month means) (Table 8). 
The association was not seen with total fruit consumption in the three-month 
postpartum period.
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.







0 2 4 6 108
Consumption of fruit during last trimester (sum of servings per day)
Figure 9. The association between ^PBDE levels in breast milk and 
consumption of fruit during the last trimester.
Table 8.
Association between PBDEs and fruit consumption during the iast trimester
Transformed p® p value Adjusted p" p value'
]£PBDEs and 
fruit consumption
0.87 0.02 0.80 0.02
BDE-47 and 
fruit consumption
0.86 0.01 0.80 0.02
Note. ®The p coefficients provide the fold change in PBDE concentrations in breast milk per unit 
of exposure (servings); Adjusted for calorie and carbohydrate consumption during the last 
trimester.
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Table 9.
The effect of confounding on fruit consumption
Confounders
Fruit Consumption (Exposure)




Calorie consumption 0.48 0 .8 f
during the last trimester (p = 0.002) (0.71,0.93)
Carbohydrate consumption 0.56 0.79^
during the last trimester (p< 0.001) (0.70, 0.92)
Note.  ^Crude p was 0.87 (95% Cl = 0.78 -  0.98).
PBDE Levels in Breast Milk and Maternal Environment
There were no associations between ^PBDE levels in breast milk and 
geographical location (e.g. town vs. city), subject occupation, transportation (e.g. 
year automobile was purchased, hours per week in the car), and other possible 
PBDE exposures (e.g. hobbies that involved using fabric). Usage of household 
appliances and electronic equipment was not associated with %^ PBDE levels in 
breast milk, nor was their year of purchase. The sum of cushioned furniture in 
the home was not associated with ^PBDE levels in breast milk, nor was the year 
of purchase. Similar findings were also seen with congener (BDE-47 and BDE- 
153) levels and living/occupational characteristics: however, an association was 
seen between BDE-153 and the home model (r= 0.51 p = 0.004) (Table 10), 
which included the total number of rooms in the home with curtains/valences and 
total number of rooms in the home with carpeting. To reach the final home
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model, backward regression was used with a threshold of p < 0.05 for keeping a 
variable in the model. The association persisted between the home model and 
BDE-153 after adjusting for total rooms in the home and total months at current 
residence (r= 0.53 p = 0.02, participant three-month means). Total rooms in the 
home and months at current residence were included as confounding variables 
based upon their association with the home model and their effect on the p 
coefficient (Table 11).
Table 10.
Association between BDE-153 and the home model
Home Model Transformed p® p value Adjusted p" p value"
Total number of rooms with 
curtains/valences
1.24" 0.002 1.21 0.007
Total number of rooms with 
carpeting
0.86'= 0.056 0.86 0.08
Note. The p coefficients provide the fold change in BDE-153 concentrations in breast milk per 
unit of exposure (rooms); indicates a fold change or 24% increase; ° indicates a fold change or 
14% decrease; '‘Adjusted for total rooms in the home and total months at current residence.
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Table 11.
The effect of confounding on the home model
Confounders Spearman’s Correlation Coefficient Adjusted p
(p value) (95% Cl)
Curtains Carpet Curtains® Carpet"
Total rooms 0.29 0.21 1.22 0.84
in home (p = 0.13) (p = 0.19) (1.08, 1.41) (0.72, 1.0)
Total months 0.28 -0.25 1.21 0.88
at residence ip = 0.07) (p = 0.11) (1.07, 1.40) (0.74, 1.0)
Note. Crude p was 1.24 (95% Cl = 1.1 -  1.4). 
" Crude p was 0.86 (95% Cl = 0.74 -  1.0)
discussion
This was the first study to document PBDE levels in breast milk of women 
from the state of New Hampshire. Our study had three main findings which 
.were: 1.) BDE-153 and its congener pattern; 2.) BDE-153 and its relationship to 
age, the home, and saturated fat; and 3.) PBDE levels (X and BDE-47) and its 
relationship to fruit consumption.
BDE-153: Congener Patterns
Even though BDE-47 was the predominant congener in most of our 
participants’ breast milk samples, a predominance of BDE-153 was observed in 
20% of the study population -  the highest percentage in the U.S. compared to 
7% (Wu et al., 2007), 8% (She et al., 2007), and 10.5% (Sjôdin et al., 2008).
Two European studies that have documented BDE-153 as the predominant 
congener in breast milk samples report high seafood consumption in their
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subjects (Fàngstrôm et al., 2005; Ingelido et al., 2007); however, an association 
between BDE-153 and seafood was not seen with these studies. It’s noted that 
the congener profile for seafood items in these European regions do not reflect 
BDE-153 as the predominant congener, which is a similar observation by Ohta 
and colleagues (2002) from Japan. The source of BDE-153 is uncertain at this 
time given the lack of association with seafood.
The predominant congener pattern (BDE-47 followed by BDE-153) from 
our research is similar to the recently reported National Health and Nutrition 
Examination Survey (NHANES) data on serum concentrations of PBDEs (Sjôdin
et al., 2008) and breast milk biomonitoring studies from Japan, East coast of the
(
U.S., Pacific Northwest of the U.S. and Canada, Poland, South China, Taiwan, 
and United Kingdom (Bi et al., 2006; Chao et al., 2007; Kalantzi et al., 2004; 
Kazda et al., 2006; Ohta et al., 2002; She et al., 2007; Wu et al., 2007). Other 
breast milk biomonitoring studies have reported predominant congener patterns 
of BDE-47 followed by BDE-99 or BDE-100 (Esiami et al., 2006; Johnson- 
Restrepo et al., 2007; Kazda et al., 2004; Schecter et al., 2003), Earlier work 
from Sweden documents BDE-47 as the predominant congener followed by 
BDE-99 and BDE-153 (Meironyté et al., 1999). However, in 1972, only two 
PBDE congeners were detected in breast milk samples from Sweden (BDE-47 
and BDE-153).
Correlation analysis revealed that BDE-153 had no correlation to BDE-47; 
however, as the ^PBDE increased in breast milk so did each of the congeners 
(Figures 3a and 3b). BDE-153 is considered to be a minor component of the
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pentaBDE and octaBDE commercial products (La Guardia et al., 2006), however, 
its estimated half-life is three times longer than that of the BDE-47 congener (6.5 
years vs. 1.8 years, respectively) (Geyer et al., 2004), and it’s suggested that 
over time, BDE-153 will become the predominant congener in the body 
(Sandanger et al., 2007). The apparent increase in the predominance of BDE- 
153 in breast milk samples from New Hampshire is suggestive of a shift in 
congener patterns, which couid be related to when our samples were collected 
(2005-2006) relative to other studies (e.g. 2004-2005) (Wu et al., 2007).
BDE-153 and Age
Our finding of an association between age and BDE-153 levels is the first 
breast milk biomonitoring study to document this positive relationship in 22 to 40 
year old women, which may be an indicator of the long half-life of this congener 
paired with the physiological demands of lactation on the body. However, we 
noted that the association between age and BDE-153 weakened when we 
accounted for changes in body composition due to weight changes. Sjôdin and 
colleagues (2008) recently reported a linear decrease and positive quadratic 
trend with age and serum concentrations of BDE-153 with the highest levels in 
the 12 to 19 year old group. These findings are not necessarily comparable to 
ours as Sjôdin et al. (2008) looked at age groups from 12 to 19, 20 to 39, 40 to 
59, and 60 + years. Sjôdin et al. (2008) did not stratify across their age groups, 
such as the 20 to 39 year olds, which was the total range for our study, and the 
NHANES population included both males and females.
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PBDE Levels and Exposure Sources
We found a statistically significant association between the home model 
and BDE-153. To our knowledge, this is the first study to document a 
relationship between BDE-153 levels in breast milk and living environment. It is 
unclear from our results whether or not the household items themselves (e.g. 
curtains/valences) or the dust they collect are the sources of the exposure, or if 
there was an association between household dust concentrations and PBDE 
sources (e.g. furniture, curtains, electronics) as recently described by Allen et al. 
(2008). We were not able to make this distinction because we did not sample 
house dust from the homes of our participants nor did we measure bromine 
concentrations in consumer products.
We noted several trends with some of our living environment data. For 
example, we found that those who used their microwave less than 6 times per 
week had lower ^PBDE levels as compared to those who used it greater than 
one time per day (p = 0.086). We also observed lower ^PBDE levels in those 
with newer (2000 to present) all-in-one stereo equipment compared to older 
models (prior to 1999) (p = 0.086). Those with newer cushioned desk chairs 
(2000 to present) had lower XPBDE levels compared to those with older 
cushioned desk chairs (prior to 1999) (n = 18, n = 9, respectively, p = 0.053).
We were surprised with the limited findings between PBDE levels and 
dietary intake given the recent work by Wu and colleagues (2007) who reported 
positive associations between PBDE levels in breast milk and the consumption of 
dairy products and meat pre-pregnancy. Our limited findings may be attributed to
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the study’s small sample size and our choice of timing for collecting dietary 
information (two 3-month periods). Perhaps if we expanded our time frame for 
assessing dietary intake (e.g. throughout the entire pregnancy), we may have 
encountered different results, especially since the half-lives of many congeners 
are on the magnitude of years. However, we did find a small, but statistically 
significant, positive association between BDE-153 levels and saturated fat intake 
during the three-month postpartum period. Of interest, this finding was not seen 
during the last trimester. The significant finding during the postpartum period 
may reflect the metabolic demands that are induced on the body with the process 
of lactation. BDE-153 is present in foods that contain saturated fat (e.g. meat, 
meat fat, dairy) based on the findings from market basket surveys in the U.S. 
(Huwe & Larsen, 2005; Schecter et al., 2004), however, it’s not a predominant 
congener in these food samples.
To our knowledge, this is the first study to find a statisticaliy significant, 
negative relationship with food consumption and PB.DE levels in breast milk. The 
association between fruit consumption and PBDE (X and BDE-47) levels during 
the last trimester suggests that fruit may contribute less to PBDE body burden. 
Our finding with fruit consumption corresponds with vegan trends that were 
observed by Schecter et al. (2006a) where blood levels of PBDEs were lower in 
those participants who had longer time periods without consuming foods of 
animal origin. However, we were surprised with our lack of findings between 
vegetable consumption and PBDE levels.
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Estimated Infant Intake of PBDEs from Breast Milk
In addition to determining levels of PBDEs in breast milk samples from 
lactating women, we were able to estimate infant exposure to PBDEs. We 
estimated infant intake of PBDEs using previously published guidelines 
(Lovelady et al., 2002); however, we did not collect information from our 
participants on infant weights and daily breast milk intakes. We estimated the 
infant weight based upon the 50*^  percentile weight for age clinicai growth charts 
using 4.3 kg for month one, 4.9 kg for month two, and 5.8 kg for month three 
(U.S. DHHS, CDC, 2001 ). The majority of participants in our study were 
exclusively breastfeeding their infants, so we assumed that the daily 
consumption of milk was 800 ml (Dewey et al., 1991 ; Kent et al., 2006).
The estimated median daily intake of PBDEs for an infant from the 
Seacoast region of New Hampshire at one month of age was 197 ng/kg body 
weight, month two was 140 ng/kg body weight, and month three was 105 ng/kg 
body weight. The estimated daily PBDE intake for infants from New Hampshire 
is higher compared to breastfed newborns from Taiwan (20.6 ng/kg body weight), 
one-month olds from Western Massachusetts (4 ng/kg body weight for three 
selected congeners), and three-month olds from Finland and Denmark (16 ng/kg 
body weight) (Chao et al., 2007; Johnson-Restrepo et al., 2007; Main et al.,
(
2007). However, the estimated daily intake for PBDEs is higher in Texas (306.6 
ng/kg body weight) and Canada (280 ng/kg body weight) compared to New 
Hampshire (Jones-Otazo et al., 2005; Schecter et al., 2006b). At this time, it is 
not clear as to what the implications are of estimated infant intakes of PBDEs; as
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noted by Jones-Otazo et al. (2005), average intakes are below the chronic oral 
reference dose (RfD) that has been established by the U.S. Environmental 
Protection Agency (1990a; 1990b; 1995) for penta (RfD = 0.002 mg/kg body 
weight/day), octa (RfD = 0.003 mg/kg body weight/day), and deca (RfD = 0.01 
mg/kg body weight/day).
Comparing and Contrasting Breast Milk Biomonitoring Studies from the U.S. & 
British Columbia
PBDE levels among studies of breast milk in the U.S. and British 
Columbia differ in ranges and median values with our study exhibiting the lowest 
maximum PBDE level (Table 12) and only one participant who had levels that 
were greater than 100 ng/g lipid. However, our median ^PBDE and BDE-47
levels are similar to levels reported by Wu and colleagues (2007) from the
■
Boston, Massachusetts area; it’s noted that our median BDE-47 levels are lower 
compared to the NHANES data (Sjôdin et al., 2008). Our study had the lowest 
number of congeners represented in ]£PBDEs, our sum did not include BDE-209, 
and our percent detection was lower for some of the major congeners (BDE-85, 
BDE-154, and BDE-183) compared to Wu et al. (2007) all of which could have 
contributed to our lower maximum levels. When comparing the median value of 
the predominant congener (BDE-47) in each of the breast milk biomonitoring 
studies, the lowest median value was from samples collected in the Western 
Massachusetts area (Johnson-Restrepo et al., 2007).
A common finding among studies in the U.S. as well as worldwide (Akutsu et al., 
2003; Bi et al., 2006; Chao et al., 2007; ErdogruI et al., 2004; Esiami et al..
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2006; Ingelido et ai., 2007; Jaraczewska et al., 2006; Kalantzi et al., 2004; Kazda 
et al., 2004; Lind et al., 2003; Main et al., 2007; Meironyté et al., 1999; Norén & 
Meironyté, 2000; Ohta et al., 2002; Ryan & Patry, 2000), is the predominance of 
the BDE-47 congener in breast milk samples. The pentaBDE commercial 
mixture contained 24 to 38% of BDE-47. PentaBDE was primarily used to flame 
retard polyurethane foams up until its voluntary phase out at the end of 2004 
(Hale et al., 2003; WHO, 1994) and BDE-47 was considered a major contributor 
to the commercial mixture (Birnbaum & Staskal, 2004). With its persistent and 
high lipophilic characteristics as well as its distribution in U.S. homes (Stapleton 
et al., 2005; Wu et al., 2007), BDE-47 bioaccumulates in humans (Hale et al., 
2003), which would provide an explanation for its predominance in breast milk 
samples.
It can be challenging to compare and contrast the results of breast milk 
biomonitoring studies because differences exist among study designs and 
congener anaiyses. As noted in Table 12, XPBDEs is defined from 8 to 35 
congeners depending on the study. If assessing whether or not labs are 
comparable, the percent detection is a useful measure, but not always available 
from published studies. In addition, breast milk biomonitoring research in the 
U.S. and British Columbia exhibit similarities and differences in their participant 
profiies and study designs (Table 13), which couid potentially influence PBDE 
levels in breast milk.
Guidelines have been established by the WHO (2007) that recommends 
recruiting first-time mothers for biomonitoring studies as previous elimination of
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environmental chemicals through lactation would not have occurred. Most 
participants enrolled in our study were first-time mothers (n = 31), but 21.5% (n = 
9) had delivered and/or nursed one or more previous children. We did not find a 
relationship between parity and PBDE concentrations nor did we see an 
association with prior breastfeeding history that would indicate lower PBDE 
levels.
Study design recommendations have suggested hand-expressing 
samples for breast milk biomonitoring research in order to limit sample 
contamination from breast pumps. However, Hooper et al. (2007) and Main et al. 
(2007) documented that breast pump use is an acceptable method for milk 
collection when analyzing samples for PBDEs, therefore methods of milk 
collection (hand vs. pump expression) should not influence PBDE levels. It is 
important to ensure that breast milk samples are not exposed to ultraviolet light 
or stored in plastic containers; amber glass storage containers can meet both of 
these specifications to minimize ultraviolet light exposure and limit adherence of 
lipid-soluble PBDEs to the storage container.
Lovelady and colleagues (2002) suggest collecting serial samples rather 
than one sample of breast milk to account for changes in environmental 
chemicals over time. Our results indicate no significant difference in mean PBDE 
levels from months one, two, and three, which is a similar finding to Hooper et al. 
(2007) in which the 0-28 days after birth group was not different from the 29 to 56
days after birth group. Additionally, over the long-term. Hooper and colleagues
\
(2007) found that depuration of PBDEs by lactation is slow in primiparae,
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averaging 1 to 3% per month or a 12 to 18% decrease after six months. 
Consequentiy, it appears that one breast milk sample would estimate PBDE 
levels.
There appears to be a gap in the biomonitoring literature that evaluates if 
the time of day and/or quantity of milk collected (e.g. complete expression vs. 
foremilk expression) influences lipid-adjusted PBDE levels in breast milk. It’s 
noted that collection amounts vary from study to study and most likely collection 
times (Table 13); however, median ][PBDE and BDE-47 levels are similar 
between Boston, Massachusetts (Wu et al., 2007) and our work (Table 12) 
suggesting that a standardized timing protocol for milk collection and a complete 
expression may not be necessary. This gap in knowledge could be answered in 
future breast milk biomonitoring research of PBDEs.
Strengths and Limitations of Our Research
There were several strengths to our study. First, the collection of serial 
breast milk samples enabled us to evaluate changes in PBDE levels over time. 
Our results further contribute to a small body of evidence that minimal changes 
exist in PBDE levels in breast milk over the first three-months postpartum. An 
additional strength to our study was a standardized milk collection protocol and 
the collection of a complete expression, which provided information on these 
parameters and their influence on lipid-adjusted PBDE ievels in breast milk.
We also viewed our survey work as strengths to our study because this 
evaluated potential exposure sources. To our knowledge, this is the first study to 
inquire about year of purchase on items in the mother’s environment that are part
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of her day-to-day living, such as electronics, appliances, and cushioned furniture. 
We also standardized lifestyle and living environment questions from the Greater 
Boston PBDE Body Burden Project (Wu et al., 2007). Although we had a 
different population in our study, we had similar findings for questions such as 
smoking, occupational, and hobby exposures. We attempted to reduce 
measurement error by pilot testing the Maternal Environment Survey prior to its 
implementation.
The use of a validated food frequency questionnaire was a strengtfvto our 
study: we were confident with the accuracy of the instrument used to assess 
dietary intake based upon its validation for the Women’s Health Initiative 
(Patterson et al., 1999). In addition, we obtained a comprehensive analysis of 
125 nutrients, and quantified the frequency and amount of food consumption for 
27 selected questions, which provided a substantial amount of dietary 
information - an important aspect given that diet is considered to be a source of 
exposure.
In general, collecting dietary information can pose a challenge in obtaining 
accurate information due to prevarication bias, the reliance on memory, and the 
estimation of portion sizes. As noted by Willet (1990), food frequency 
questionnaires have their drawbacks including restrictions in collecting 
information with fixed food lists, which we encountered as we were unable to 
distinguish between kinds of dairy fat consumed since some participants included 
multiple types. Since Wu and colleagues (2007) found an association between
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XPBDE levels In breast milk and consumption of dairy fat, this would have been 
an important aspect to evaluate from our data.
Our findings are limited due to the small sample size and our specific 
population of nursing mothers, therefore our results may not be applicable to the 
general population. As noted from previous research, infants ingest more 
PBDEs compared to adults (Jones-Otazo et al., 2005; Schecter et al., 2006), and 
males are 2.1 times more likely to be above the 95*^  percentile for BDE-153 as 
compared to females (Sjôdin et al., 2008).
Conclusions and Future Directions for Breast Milk Biomonitoring of PBDEs
This was the first study in the state of New Hampshire to document and 
evaluate PBDE levels in nursing mothers over time. Our results indicate that 
PBDE levels from New Hampshire are within the range that has been reported in 
the U.S., and that levels are stable during the first three-months of lactation. Our 
findings revealed a higher predominance pattern with BDE-153 compared to 
other studies, which may be reflective of its long half-life. Our data indicates that 
PBDE levels are influenced by age, diet, and the home environment. Our diet 
and home environment findings contribute to the limited body of knowledge on 
exposure sources of PBDEs. The negative association between fruit 
consumption and PBDE (% and BDE-47) levels during the last trimester was 
surprising, and suggests that fruit may contribute less to PBDE levels in the 
body.
In the future, it will be important to document time-trends of PBDEs given 
the recent phase-out of pentaBDE and octaBDE commericial products and to
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further evaluate geographical trends in the U.S. Lastly, further research should 
assess for potential health consequences associated with PBDE body burden 
and the nursing infant, with a focus on the long half-life congener BDE-153.
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CHAPTER V
MANUSCRIPT 2: DEVELOPING A BIOMONITORING 
COMMUNICATION PAMPHLET FOR POTENTIAL PARTICIPANTS IN A 
BREAST MILK BIOMONITORING STUDY
introduction
The National Research Council (2006) emphasizes early planning as an 
important component in communicating biomonitoring information. Early 
planning enables researchers to assess the needs of the study population and to 
establish partnerships with other constituencies in formulating public health 
messages. Early planning also encourages researchers to consider both 
practical and research-based communication recommendations.
Practical recommendations focus on educational aspects, whereas, 
research-based recommendations promote the advancement of biomonitoring 
communication (National Research Council, 2006). Practical biomonitoring 
communication recommendations highlight the following areas: communication 
sponsorship, use of consistent terminology and concepts, expansion of 
biomonitoring education to the public on how to interpret biomonitoring results, 
communication training for organizations and professionals, and public 
documentation of ways to reduce exposures. Research-based recommendations 
emphasize the following areas: identification of scientist and non-scientist beliefs 
about exposures and health effects, assessment of current biomonitoring
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communication methods and its impact on the public, identification of the public’s 
perception regarding uncertainties in biomonitoring, and identification of the 
public’s beliefs about risk reduction. Employing aspects of these communication 
recommendations would enhance the efforts of biomonitoring research.
If communication is lacking between biomonitoring researchers and the 
general public, then the results of biomonitoring studies are subject to 
misinterpretation and misuse, which can lead to public health messages that 
induce confusion, conflict and anxiety. For example, occasionally, the media will 
become aware of biomonitoring research, and will provide a condensed, 
simplified version of the results (Bates et al., 2005). Often, these types of 
messages present a communication risk, particularly if the biological specimen is 
sensationalized with a degree of harm, which can happen when environmental 
chemicals are detected in breast milk.
Breast milk is a valuable matrix for monitoring body burdens of 
environmental chemicals: however, there are positive and negative aspects when 
using breast milk to assess human exposure to environmental chemicals (Fenton 
et al., 2005; Hooper & She, 2003). Fenton and colleagues (2005) identify 
limitations with using breast milk in biomonitoring studies as the interpretation 
and communication of study results have the potential for affecting breastfeeding 
rates if inaccurate messages are provided to the public. Even though there are 
limitations associated with breast milk biomonitoring studies, positive aspects 
have been identified including the collection of a biological specimen with a high 
fat content. This positive aspect is an important consideration for iipid-soluble
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environmental chemicals -  particularly those that have been steadily rising in 
their production, use, and presence in the environment and in humans including 
synthetic flame retardants such polybrominated diphenyl ethers (PBDEs).
PBDEs in breast milk were first reported by Krüger (1988) in German 
samples, and later by Meironyté et al. (1999) in Swedish samples. PBDE 
concentrations in Swedish breast milk samples increased from 1972 to 1997, and 
it was determined that levels were doubling every five years while levels of other 
environmental chemicals (PCBs and DDT) were decreasing during this same 
time period (Meironyté et al., 1999; Norén & Meironyté, 2000). Documenting 
this exponential increase in PBDEs has resulted in breast milk biomonitoring 
initiatives around the globe, but with limited consideration to practical and 
research-based communication recommendations. One of the primary research 
objectives of Biomonitoring PBDEs in Lactating Women was to develop an 
informative, yet réassuring communication pamphlet to educate potential 
subjects about the research without scaring mothers away from nursing their 
infants.
the process
To address this objective, we drafted a communication pamphlet. The 
format of the pamphlet contained short sections about the research study, body 
burden, what PBDEs are and where they come from, why we are measuring 
PBDEs, what we hope to learn from the study, and the importance of 
breastfeeding. The final draft of the communication pamphlet also included a 
section on “frequently asked questions”.
118
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
As part of the communication pamphlet development phase, we 
collaborated with a health promotion advisor from the New Hampshire 
Department of Health and Human Services (DHHS), a faculty member from the 
Family Research Laboratory at UNH, the New Hampshire Breastfeeding Task 
Force and a focus group of women from the community. This collaboration 
provided us with valuable feedback on the content and language of the pamphlet.
Our first collaborative meeting was in March 2005 with the DHHS health 
promotion advisor and the faculty member from the Family Research Laboratory. 
Their primary recommendations were to eliminate the technical language in order 
to decrease the reading level from 12^ *^  grade to 8“  ^grade. In addition, they 
recommended that the pamphlet be visually appealing and be reassigned a less 
scientific name. The project’s secondary name became Steps to a Healthy 
Future.
Our second meeting was in April 2005 with 20 members of the New 
Hampshire Breastfeeding Task Force. The members of the Task Force are 
primarily registered nurses and registered dietitians who are lactation specialists. 
This meeting provided valuable input regarding appropriate breastfeeding 
language and further elimination of technical wording. An added advantage of 
this meeting was that members of the Task Force provided helpful suggestions
on our biomonitoring research design including sample collection time, sample
;
size, breastfeeding support to participants and information on personal use vs. 
rental breast pumps.
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Our third meeting was in May 2005 when we conducted a six person, one 
hour focus group to assess the content of the pamphlet. We recruited women 
from the UNH campus who were currently breastfeeding or had breastfed their 
child within the last two years. We provided background information on the 
study, reviewed each section of the communication pamphlet, and collected 
verbal and written feedback from the focus group participants. The verbal 
feedback emphasized refinement of language to further improve the readability of 
the communication pamphlet. The written feedback was collected by having 
participants compiete an anonymous 10-question survey about the content and 
clarity of the pamphlet at the end of the focus group session. The written 
feedback directed us to emphasize the heaith effects of PBDEs, participant time 
commitment and what will happen with the final results of the study.
The communication pamphlet was completed in August of 2005. The 
final format was an eight page pamphlet with readability statistics at the 5‘  ^grade 
reading level. Approximately 1500 copies of the pamphlet were distributed to 
lactation consultants and placed in eight locations around the Seacoast area of 
New Hampshire (Dover Pediatrics, Exeter Hospital Family Center, Harbour 
Women’s Health, Lamprey Health Care, Portsmouth Regional Hospital,
Rochester Women, Infants & Children Clinic, Seacoast Area La Leche League, 
and Wentworth Douglass Hospital) for subject recruitment.
Participants were recruited from the Seacoast region of New Hampshire 
from November 2005 to Juiy 2006. Recruitment was accomplished by iactation 
consultants from three area hospitals -  Exeter Hospital, Portsmouth Regional
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Hospital, and Wentworth Douglass Hospital -, distribution of the communication 
pamphlet, and word of mouth. Approval from each hospital was obtained prior to 
working with the lactation consultants. Monthly breastfeeding classes were 
attended by the researchers at each of the hospitals to provide study information 
and the communication pamphlet to pregnant women. The lactation consultants 
provided the communication pamphlet to postpartum women prior to their 
discharge from the hospital. In addition, the pamphlet was distributed to 
outpatient health care clinics.
the outcome and conclusions
All 40 participants in the Biomonitoring PBDEs in Lactating Women 
research study received a copy of the communication pamphlet. Thirty-eight 
percent of the participants received the pamphlet from a lactation consuitant; 
twenty-eight percent of the participants received the pamphlet at breastfeeding 
classes: twenty-three percent through a friend/colleague; and thirteen percent 
through picking up the pamphlet at area hospitals or outpatient health care 
clinics.
The communication pamphlet assisted us in conveying information 
pertinent to our study to potential participants. We discovered that our process, 
after the publication of Human Biomonitoring for Environmental Chemicals 
(National Research Council, 2006), employed some of the principles of practical 
and research-based communication recommendations. For example, our 
pamphlet discussed the uncertainties that exist between PBDE leveis in humans 
and health effects. Additionally, we included in the communication pamphlet our
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approach on how we would disseminate the results of our study. We decided to 
use a ciinicai medicine model approach, which emphasizes minimizing potential 
harm from reporting uncertain information (Brody et al., 2007). We informed 
participants that they would not receive individual results as there is not enough 
information to interpret the meaning of PBDE levels in humans.
It is noted that practical and research-based recommendations 
emphasized by the National Research Council (2006) primarily focus on 
communicating and interpreting the results for the public. However, our 
approach to the communication pamphlet focused on providing information to 
potential participants prior to their commitment to our biomonitoring study. In 
addition, we focused on fostering partnerships with organizations and 
professionals (e.g. New Hampshire Breastfeeding Task Force and lactation 
consultants) to provide them with an understanding of biomonitoring and our 
research prior to recruiting participants into the study.
For future biomonitoring research, we would utilize this process again. 
However, we would assess the effectiveness of our communication pamphlet 
with participants who enrolled in the study through either a questionnaire or focus 
group. We wouid further implement additional practical and research-based 
communication recommendations in an effort to further advance the work of 
biomonitoring research.
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CHAPTER VI 
CONCLUSIONS AND FUTURE DIRECTIONS
This was the first study in the state of New Hampshire to document and 
evaluate PBDE levels in nursing mothers over time. Our results indicate that 
PBDE ieveis from New Hampshire are within the range that has been reported in 
the U.S., and that levels are stable during the first three-months of lactation. Our 
findings revealed a higher predominance pattern with BDE-153 compared,to 
other studies, which may be reflective of its long half-life. Our data indicates that 
PBDE levels are influenced by age, diet, and the home environment. Our diet 
and home environment findings contribute to the iimited body of knowledge on 
exposure sources of PBDEs.
We found that our communication pamphlet assisted us in conveying 
information pertinent to our study to potential participants. For future 
biomonitoring research, we would utilize this process again. However, we would 
assess the effectiveness of our communication pamphlet with participants who 
enroiled in the study through either a questionnaire or focus group.
In the future, it will be important to document time-trends of PBDEs given 
the recent phase-out of pentaBDE and octaBDE commericial products and to 
further evaluate geographical trends in the U.S. Lastly, further research should 
assess for potential health consequences associated with PBDE body burden 
and the nursing infant, with a focus on the long half-life congener BDE-153.
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UNIVERSITY o/ NEW HAMPSHIRE
B io m o n ito r in g  P B D E s  in  L a c ta t in g  W o m e n  
Focus Group Questionnaire for Educational Tooi
1. After hearing the script, do you feel the importance of breast feeding is 
sufficiently emphasized?
Yes No
If no, do you have suggestions for improving this area?
2. If you were a potential participant, do you feel the information on human 
research is helpful?
Yes No
If no, do you have suggestions for improving this area?
3. Do you understand the term “body burden”?
Yes No
If no, what would help in clarifying the term?
4. Do you understand why we’ve chosen breast milk as our “window” into the 
human body?
Yes No
If no, what would help in clarifying this area?
5. Can you identify where PBDEs come from?
Yes No
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6. Can you identify the potential health effects of PBDEs?
Yes No
7. Do you feel there is enough information on the following areas in regard to 
each participant’s obligation to the study:
a. Time commitment
Yes No




8. If you were a participant in this study and PBDEs were detected in your 
breast milk, would you stop breast feeding?
Yes No
How would you feel?
What questions would you have?
9. Do you understand what will happen with the results of the study?
Yes No
10. Do you have suggestions for the visual component of the educational 
tool?
Yes No
If yes, please describe.
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S t e p s  t o  a  
H e a l t h y  
F u t u r e
Planning to breast feed?
Would you like to participate in 
a research study?
R e a d  o n . . . .
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Overview:
Y O U  A R E  E L IG IB L E  IF ;
• You are pregnant and plan to breast 
feed.
OR
• You are a new mother who has been 
breast feeding for less than 2 weeks.
Y O U R  R O L E  W O U L D  B E ;
• To provide us with up to 9 breast milk 
samples over 3 months.
• To meet with us on 4 occasions (at UNH 
or at your home).
• To complete diet and environment 
surveys.
O U R  G IF T  T O  Y O U !
• A P urely Yours personal breast pump.
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Our G oal....
To learn more about environmental 
chemicals that build up in the body 
also known as “body burden.”
How does **body burden” happen?
We are exposed to chemicals each day, and 
some are stored in our bodies. We may breathe 
in environmental chemicals, eat them in food, 
or even absorb them through our skin.
What chem icals are we interested in?
Since the 1970’s, a family of chemicals that has 
increased dramatically in our environment is 
p o ly b r o m in a t e d  d ip h e n y l  e t h e r s ,  also 
known as PBDEs.
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What are PBDEs?
Chemical flame retardants. They keep 
things from burning.
Where are PBDEs found?
PBDEs are in products like couches, 
stereos, carpets, television sets, and 
computers.
Why m easure PBDEs?
Research using laboratory animals 
suggests that high levels of PBDEs in 
animals can interfere with thyroid 
hormone, learning, memory, and 
behavior.
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Can th ese  sam e health  effects  
  happen in  people?
We don’t know. A first step is to 
measure PBDEs in people.
How w ill w e m easure PBDEs?
We can measure PBDEs in blood or 
breast milk. But, breast milk is a better 
window into the human body. W h y ?
PBDEs collect in body fat, and breast 
milk contains fat.
What w e w ill leam :
• This study will help us to leam about 
PBDEs in the Seacoast region of New 
Hampshire.
• We hope to find out if there are 
relationships between PBDEs, diet and 
environment.
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To thank you.
Each participant will receive a 
Purely Yours personal breast pump.
Breast milk is the most nourishing food you can 
give your baby.
Whether or not you decide to participate in the 
Steps to a  H ealthy Future study, know that 
you are making the right choice in 
breastfeeding your baby.
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If you would like more 
information on the 
S t e p s  t o  a  H e a l t h y  F u t u r e
research study, please contact:
Gale Carey or Rebecca Dunn
at the University o f New Hampshire,
6 0 3 - 8 6 2 - 2 5 5 0
University of New Hampshire
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Frequently Asked Q uestions
1. Will my participation interfere with breast 
feeding my baby?
No
2. How many breast milk samples will I provide?
A maximum of 9 samples
3. What is the size of each sample?
Each sample will be one complete expression from  
one breast.
4. Will I receive instructions on how to collect and 
store breast milk samples?
Yes, this w ill happen on your first visit with us.
5. What if I have difficulty breast feeding?
Breast feeding support is available from a 
professional lactation consultant.
6. What if I have to stop breast feeding?
I f  you stop breast feeding due to unforeseen 
circumstances, ju s t let us know. You are free to 
leave the study at any point.
1. What will happen to the results of the study?
The anonymous results w ill be published in a 
scientific journal. '
8. Will I receive my PBDE levels?
No, individual levels w ill not be provided as there is 
not enough information to know what the levels 
m e a n . B u t , yo u  w i l l  receive a  s u m m a ry  o f  the  
findings and the published report.
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U n iv e r s it y  0/ N ew  H a m p s h ir e
INSTITUTIONAL REVIEW BOARD FOR THE PROTECTION OF HUMAN SUBJECTS IN RESEARCH
INFORMED CONSENT FOR PARTICIPANTS:
STEPS TO A HEALTHY FUTURE
Purpose: The purpose of this study is to collect Information on levels of polybrominated diphenyl ethers (PBDEs) In
breast milk, and to determine If there is a relationship between PBDE level, maternal characteristics and 
the environment.
Description: You are being asked to participate in a 3-month study through the University of New Hampshire. We are 
In need of 100 lactating women, ages 22 to 40, who are In the early stages of breastfeeding (less than 2 
weeks) or In the last trimester of pregnancy and plan on breastfeeding. We are asking for a maximum of 
9 breast milk samples during the first three months of breast feeding. One sample is the equivalent of 
one complete expression from one breast. You will provide up to 3 sampies at the end of the first, 
second, and third month of breast feeding.
You are being asked to completely express milk from one breast In the morning on 3 successive days, 
once per month for three months. You are being asked to gently mix the milk and transfer your breast 
milk sample to a storage container and place It In the refrigerator.
You are being asked to visit with the University of New Hampshire researchers on 4 occasions over a 3- 
month period for a total of approximately 6 hours. On the first visit, you will be oriented to the study's 
purpose and design, asked to complete a food frequency questionnaire and a maternal characteristics 
survey and sign the subject consent form. You will receive Instruction on breast milk expression via a 
personal use breast pump, sample collection procedure and sample storage. You will be given a kit 
containing written instructions, milk storage containers, and a milk transport cold box (if needed).
The second visit will occur after 1 month. You will surrender your first month’s samples (up to 3 samples) 
and meet with the researchers to answer any questions. You will be asked to complete an environmental
survey. The third visit will occur after the second month. You will surrender the second month's samples
(up to 3 samples) and meet with the researchers to answer any questions. The fourth visit will occur at 
the end of the study, when you will surrender the third month's samples (up to 3 samples), complete a 
food frequency questionnaire and receive study debriefing.
To show our appreciation for your time, you will recqlve a personal use breast pump and pumping kit 
during your first visit with the researchers. In addition, you will also be provided with breast feeding 
support from a professional lactation consultant.
We will share our results with the scientific community; the route by which scientists communicate with 
their peers and the larger community. We will provide you with the same published Information. After we 
have published our results, you may hear about the study on television or In the newspaper.
To ensure confidentiality of subject Information, all data will be stored In a locked room within the graduate 
student office (418 Kendall Hail) at the University of New Hampshire. Data will be coded to Insure your 
privacy. You will be assigned a number, which will be used on all the records of data collected and no 
names will be disclosed.
Potential Risks to you could be psychological harm. Although we will release only cumulative data on all
Risks; subjects, not Individual data on each subject (as there Is no context In which to evaluate this data),
you may feel anxious knowing that your breast milk contains PBDEs. In order to address this
possibility, you will be asked to view our education tool at the outset of the study.
Although unlikely, some slight breast discomfort may occur due to the use of the breast pump.
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1. You understand that the use of human subjects in this project has been approved by the University of New 
Hampshire Institutional Review Board for the Protection of Human Subjects In Research.
2. You understand the purpose of this research project, the procedures to be foilowed, the expected duration of your 
participation, and have viewed the educational tool.
3. You have received a description of any reasonable foreseeable risks or discomforts associated with being a subject 
In this research, have had them explained to you, and understand them.
4. The Investigator seeks to maintain the confldentlality of all data and records associated with your participation In this 
research. You should understand, however, there are rare Instances when the Investigator Is required to share 
personally-ldentlflable Information (e.g., according to policy, contract, and regulation). For example. In response to 
a complaint about the research, officials at the University of New Hampshire, designees of the sponsor(s), and/or 
regulatory and oversight government agencies may access research data. You also should understand that the 
investigator is required by law to report certain Information to government and/or law enforcement officials (e.g., 
child abuse, threatened violence against self or others, communicable diseases).
5. As a participant, you have the right to revoke your consent to use personal health Information. If you chose to do 
so, contact the Project Director, Rebecca Dunn at 603-862-2550. There Is the potential risk that personal health 
Information provided to others has the potential risk of being re-dlsclosed.
6. You understand that your consent to participate in this research is entirely voluntary, and that your refusal to
participate will Involve no prejudice, penalty or loss of benefits to which you would otherwise be entitled.
7. You further understand that if you consent to participate, you may discontinue your participation at any time without 
prejudice, penalty, or loss of benefits to which you would otherwise be entitled.
8. You confirm that no coercion of any kind was used In seeking your participation in this research project.
9. In the unlikely event that physical Injury should occur from participating in this project, medical treatment should be
sought from your own health care provider. No compensation for Injury is available. If you are a UNH student and 
have a paid health fee, you may be seen at the UNH Health Services.
10. Information on University policy and procedure for research involving human subjects can be obtained from Julie 
Simpson at the Human Subjects Review Board, Office of Sponsored Research at 862-2003. Please call Dr. Gale 
Carey or Rebecca Dunn at the numbers below if you have questions regarding the procedures or any other aspect 
of this study. The Steps to a Healthy Future research study will expire In summer 2008 when data collection, data 
analysis and reporting of results Is completed.
Gale B. Carey, Ph.D. Rebecca L. Dunn, M.A., R.D., L.D.
603-862-4628 603-862-2550
I have read the following Information and have had all questions concerning this study answered to my satisfaction. 
The Information obtained will be treated as privileged and confidential and will not be released without my consent. 
However, this Information may be used for statistical or scientific purposes with my right of privacy retained. 1 
understand and agree that In the event of Injury, which I may sustain as a result of my participation, no financial 
compensation Is available but medical treatments within the limits of treatment normally offered by the University of 
New Hampshire Health Center will be available. I understand that I will be assessed a fee for any medical services.
Subject Signature Witness Signature Date
Steps to a Healthy Future
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Subject #:_
Date Pumped: _Time Pumped:
Time of Last Feeding:.
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APPENDIX H
PBDE LEVELS IN INDIVIDUAL BREAST MILK SAMPLES
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Appendix H: PBDE levels In breast milk samples from month one
Percent Lipid BDE28/33 BDE47 BDE85 BDE99 BDE100 BDE153 BDE154 BDE183 IPBDE
Month 1 Subject #
Month 1 101-05 3.7 2.9 19.2 0.3 4.4 3.6 4.6 0.3 0.1 35.4
Month 1 102-05 4.5 2.6 22.7 0.2 2.8 l l 20.4 0.1 0.04 50.9
Month 1 103-05 5.0 5.4 59.0 0.9 4.6 15.3 10.4 0.6 0.1 96.3
Month 1 104-05 5.0 2.6 29.4 0.2 3.6 2.8 2.2 0.2 0.1 41.0
Month 1 105-05 2.5 0.5 4.4 0.1 0.9 0.8 1.8 ND 0.1 8.6
Month 1 106-06 3.8 1.8 24.4 0.4 3.7 2.7 5.2 0.2 ND 38.4
Month 1 107-06 3.4 0.3 4.9 0.1 1.2 0.8 1.1 0.1 ND 8.4
Month 1 108-06 2.9 0.6 5.1 ND 0.7 0.6 2.7 ND ND 9.7
Month 1 109-06 3.4 1.3 13.7 0.1 1.4 0.8 0.8 0.1 ND 18,2
Month 1 110-06 2.8 2.1 33.7 0.5 6.6 4.5 9.0 0.3 0.21 56.7
Month 1 111-06 4.2 1.7 26.1 0.5 4.1 4.9 4.5 0.3 ND 42.1
Month 1 112-06 2.8 0.4 3.7 ND ND 0.4 9.9 ND ND 14.3
Month 1 113-06 2.1 2.9 27.1 ND 3.8 2.7 3.9 ND ND 40.5
Month 1 114-06 2.5 0.6 3.7 ND 0.6 0.4 1.5 ND ND 6.8
Month 1 115-06 , 2.7 3.4 35.5 ND 5.0 12.8 109.6 0.5 ND 166.7
Month 1 116-06 4.4 1.6 14.3 0.1 2.6 3.6 7.4 0.1 ND 29.9
Month 1 117-06 2.5 0.6 6.2 ND 1.5 1.8 97.7 ND ND 107.7
Month 1 119-06 4.6 2.6 16.7 ND 2.2 2.0 0.7 0.1 ND 24.3
Month 1 120-06 4.3 1.6 14.9 0.2 2.9 2.7 1.6 0.1 0.1 24.1
Month 1 121-06 4.3 1.7 13.0 ND 1.1 2.6 27.3 0.1 0.1 45.9
Month 1 122-06 1.6 0.5 7.7 ND ND 1.6 2.4 ND 2.3 14.6
Month 1 123-06 2.1 1.8 25.3 0.3 3.6 7.6 28.4 0.4 ND 67.3
Month 1 124-06 4.3 0.7 5.9 0.2 0.8 0.8 1.6 0.03 0.7 10.7
Month 1 125-06 1.7 1.2 11.4 ND 1.4 2.3 8.7 ND ND 25.0
Month 1 126-06 3.0 0.9 8.2 ND ND 0.8 6.9 ND 0.2 17.1
Month 1 127-06 3.2 1.0 8.1 ND ND 2.9 9.9 0.1 0.1 22.1
Month 1 129-06 2.5 3.3 34.9 ND 3.0 9.5 4.7 0.2 ND 55.7
Month 1 130-06 2.0 2.2 19.1 ND 2.5 1.6 1.7 ND 0.3 27.5
Month 1 132-06 4.4 2.2 38.9 0.6 5.7 6.2 3.2 0.4 ND 57.2
Month 1 133-06 1.6 1.1 11.4 0.2 1.7 2.1 23.6 ND ND 40.1
Month 1 134-06 2.5 1.4 11.5 0.2 1.4 2.4 8.2 0.1 ND 25.3
Month 1 135-06 4.5 0.8 5.1 0.1 0.7 0.8 1.1 0.1 ND 8.7
Month 1 136-06 3.5 2.9 33.7 0.4 3.5 3.3 1.3 0.2 ND 45.2
Month 1 137-06 4.3 1.1 9.6 0.1 0.8 4.5 13.5 0.1 ND 29.6
Month 1 138-06 3.1 3.5 31.5 0.8 5.2 8.8 5.2 0.4 ND 55.5
Month 1 139-06 2.5 4.5 19.4 0.3 2.6 4.3 13.7 0.2 ND 45.0
Month 1 141-06 4.8 0.8 9.6 0.1 1.5 1.8 7.1 0.1 ND 21.1
Month 1 142-06 4.6 1.4 9.9 0.2 1.8 3.0 7.2 0.1 ND 23.6
Month 1 143-06 4.2 0.9 8.8 0.1 ■ 1.1 1.2 1.5 0.1 ND 13.7
Month 1 144-06 2.0 1.0 11.0 0.2 2.2 1.8 3.5 0.1 ND 19.7
Minimum 1.6 0.3 3.7 < DL <DL 0.4 0.8 <DL < DL 6.8
Maximum 5.0 5.4 59.0 0.9 6.6 15.3 109.6 0.5 2.3 166.7
Median 3.3 1.5 13.4 0.2 2.4 2.5 4.9 0.1 0.1 28.6
Mean 3.3 1.8 17.5 0.3 2.6 3.4 11.9 0.2 0.4 37.3
Note. PBDE levels are reported with non-detects (NO) = 0.
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Appendix H; PBDE levels In breast milk samples from month two
Percent LIpId LIpId* BDE28/33 BDE47 BDE8S BDE99 BDE100 BDE1S3 BDE154 BDE183 yPBDE
Month 2 Subject #
Month 2 101-05 2.6 3.0 15.4 0.2 2.3 2.7 4.0 0.3 ND 27.8
Month 2 102-05 4.6 2.7 , 22.9 0.2 3.1 2.1 20.0 0.1 0.02 51.0
Month 2 103-05 4.4 4.7 54.1 0.8 4.4 15.7 11.6 0.7 0.1 92.2
Month 2 104-05 4.9 2.9 32.6 0.3 4.1 3.2 2.1 0.2 ND 45.4
Month 2 105-05 2.5 0.4 3.9 0.1 ND 0.7 1.6 ND ND 6.6
Month 2 106-06 3.3 1.6 21.0 0.2 2.8 2.2 4.1 0.1 ND 32.0
Month 2 107-06 2.4 0.4 7.6 0.1 1.9 0.9 1.0 0.1 ND 11.9
Month 2 108-06 4.4 0.5 5.0 ND 0.8 0.7 2.7 ND ND 9.8
Month 2 109-06 4.5 1.3 14.5 0.1 1.4 0.8 1.0 ND ND 19.1
Month 2 110-06 3.0 3.0 2.2 35.8 ND 7.3 4.2 7.9 0.3 0.4 58.1
Stability 110-06" 2.4 37.4 ND 9.8 5.4 8.7 0.3 0.2 64.2
Month 2 111-06 4.0 1.7 26.6 ND 4.1 5.0 5.2 0.3 ND 43.0
Month 2 112-06 1.9 0.4 4.3 ND ND 0.5 11.1 ND ND 16.4
Month 2 113-06 2.6 2.1 19.5 ND 2.5 2.0 3.1 ND ND 29.2
Month 2 114-06 1.3 0.8 4.0 ND ND 0.4 1.7 ND ND 6.9
Month 2 115-06 4.0 2.7 29.6 ND 6.6 10.4 83.8 0.6 ND 133.7
Month 2 116-06 2.4 1.6 13.8 0.2 2.4 3.3 6.9 0.1 ND 28.3
Month 2 117-06 4.4 0.5 5.0 ND 1.2 1.3 76.1 0.1 ND 84.1
Month 2 119-06 3.5 2.4 17.4 ND 2.3 2.0 0.9 0.1 ND 25.2
Month 2 120-06 1.4 1.8 19.2 0.3 3.9 3.1 1.5 0.2 ND 30.0
Month 2 121-06 3.2 1.5 11.1 ND ND 2.3 21.4 0.1 0.3 36.7
Month 2 122-06 1.5 0.5 6.2 ND ND 1.2 2.0 ND 1.1 11.0
Month 2 123-06 2.3 1.9 27.0 0.3 4.3 7.8 29.1 0.4 ND 70.7
Month 2 124-06 1.9 0.9 9.0 0.2 1.8 1.1 1.5 0.1 0.7 15.2
Month 2 125-06 2.9 1.3 10.4 ND 1.4 2.1 7.0 0.1 0.2 22.4
Month 2 126-06 4.1 1.1 10.1 ND 1.6 1.1 8.3 0.1 0.2 22.4
Month 2 127-06 1.1 1.0 7.3 ND ND 3.7 15.1 ND ND 27.0
Month 2 129-06 1.8 3.3 33.7 2.1 2.7 8.5 3.9 ND ND 54.1
Month 2 130-06 2.4 2.0 18.0 0.2 2.6 1.5 1.1 0.1 ND 25.5
Month 2 132-06 8.5 1.9 33.3 0.5 4.9 5.5 3.1 0.3 ND 49.5
Month 2 133-06 1.8 0.9 10.4 0.3 2.0 2.1 24.6 ND ND 40.2
Month 2 134-06 5.7 1.3 10.2 ND 1.0 2.3 8.3 0.1 ND 23.3
Month 2 135-06 4.3 0.8 5.5 0.1 0.6 0.8 1.1 0.1 0.3 9.2
Month 2 136-06 6.0 5.2 2.3 27.2 0.3 2.5 2.7 1.1 0.1 1.3 37.5
Month 2 137-06 3.5 1.1 9.1 ND 0.8 4.9 16.8 0.1 0.3 33.1
Month 2 138-06 2.4 3.3 29.0 0.7 4.3 7.9 4.6 0.3 ND 50.2
Month 2 139-06 1.9 4.4 20.2 0.3 3.2 4.8 16.7 0.3 ND 49.8
Month 2 141-06 3.1 0.7 8.6 0.1 1.5 1.9 8.2 0.1 ND 21.2
Month 2 142-06 5.7 1.4 9.3 0.2 1.6 3.1 8.3 0.1 ND 24.0
Month 2 143-06 2.2 0.9 8.6 0.1 1.2 1.3 1.6 ND ND 13.6
Month 2 144-06 2.1 0.9 9.6 0.1 1.5 1.4 2.9 ND ND 16.5
Minimum 1.1 0.4 3.9 <DL <DL 0.4 1.0 <DL <DL 6.6
Maximum 8.5 4.7 54.1 2.1 7.3 15.7 83.8 0.7 1.3 133.7
Median 2.9 1.4 12.4 0.2 2.4 2.1 4.3 0.1 0.3 28.1
Mean 3.3 1.7 16.6 0.3 2.7 3.2 10.8 0.2 0.4 35.1
Note. PBDE levels are reported with non-detects (ND) = 0; 'D ata represents the percent llpid content from the stability study,
“ Data In the rectangular box represents the congener profiles of the sample from the stability study. | |
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Appendix H: PBDE levels in breast milk samples from month three
Percent Lipid Llpid* BDE28/33 BDE47 BDE85 BDE99 BDE100 BDE1S3 BDE1S4 BDE183 IPBDE
Month 3 Subject #
Month 3 101-05 1.9 2.9 17.8 0.3 4.5 3.4 4.9 0.4 0.05 34.1
Month 3 102-05 2.0 2.6 20.9 0.1 2.4 1.8 f 18.5 0.1 ND 46.4
Month 3 103-05 4.6 3.9 43.5 0.7 3.6 12.0 ' 8.7 0.5 0.10 73.2
Month 3 104-05 4.5 2.6 . 30.3 0.2 4.5 3.0 2.2 0.2 ND 42.9
Month 3 105-05 1.1 0.4 3.8 0.1 ND 0.7 1.7 ND ND 6.8
Month 3 106-06 1.7 1.5 22.5 ND 3.6 2.4 4.4 0.2 ND 34.7
Month 3 107-06 4.4 0.4 7.1 0.1 1.5 0.8 1.2 0.1 ND 11.3
Month 3 108-06 1.7 0.5 5.6 ND 1.3 0.8 2.9 ND ND 11.2
Month 3 109-06 5.7 1.2 13.2 ND 1.3 0.8 0.8 0.1 ND 17.4
Month 3 110-06 4.0 3.5 2.3 42.9 ND 10.2 4.7 6.9 0.3 0.2 67.4
stability 110-06" 3.0 49.5 0.7 13.7 6.3 9.4 0.4 0.3 83.3
Month 3 111-06 3.8 1.9 31.3 ND 5.8 5.9 5.9 0.4 0.10 51.3
Month 3 112-06 1.6 0.3 5.5 0.2 2.5 0.8 8.5 ND ND 17.8
Month 3.113-06 1.7 1.2 11.9 ND 1.6 1.1 1.6 ND ND 17.5
Month 3 114-06 2.0 2.0 0.7 3.8 ND 0.8 0.4 1.6 ND ND 7.2
Stability 114-06" 0.8 4.5 0.1 0.8 0.6 1.7 ND ND 8.5
Month 3 115-06 4.3 2.2 22.7 ND 3.3 8.6 81.3 0.3 ND 118.4
Month 3 116-06 1.2 1.8 16.0 0.2 3.1 3.8 8.3 ND ND 33.2
Month 3 117-06 3.6 0.5 5.1 ND 1.0 1.3 73.7 0.1 ND 81.6
Month 3 119-06 3.8 3.3 2.1 15.1 ND 2.2 1.9 0.9 0.1 ND 22.3
Month 3 120-06 2.7 3.1 1.8 18.3 0.2 3.7 3.1 1.8 0.2 ND 29.1
Month 3 121-06 3.8 1.1 9.8 ND ND 2.3 22.1 ND 0.66 36.0
Month 3 122-06 3.9 0.5 5.7 0.4 1.0 1.2 2.1 ND 0.9 11.8
Month 3 123-06 3.3 1.6 22.5 0.2 3.2 6.5 24.2 0.4 ^ ND 58.6
Month 3 124-06 2.0 0.7 7.2 ND 1.2 0.8 1.6 0.1 0.7 12.5
Month 3 125-06 3.1 1.2 9.6 ND 1.3 2.0 6.8 0.1 0.1 21.1
Month 3 126-06 0.9 1.4 11.9 ND ND 0.6 11.1 ND 0.8 25.7
Month 3 127-06 1.6 0.7 5.3 ND ND 2.6 11.3 ND ND 19.8
Month 3 129-06 2.8 2.8 3.3 33.2 1.4 2.5 8.1 4.1 0.2 ND 52.8
Month 3 130-06 1.3 3.1 28.8 ND 3.8 2.2 2.0 ND 0.9 40.8
Month 3 132-06 3.2 2.0 34.5 0.6 5.8 5.9 3.3 0.4 ND 52.5
Month 3 133-06 1.8 1.0 9.9 0.2 1.7 2.0 25.5 ND ND 40.2
Month 3 134-06 6.8 1.2 9.4 ND 1.1 2.1 7.5 0.1 0.1 21.4
Month 3 135-06 1.9 0.6 4.0 0.1 ND 0.7 1.0 ND ND 6.5
Month 3 136-06 5.0 3.6 2.1 25.0 0.3 2.5 2.4 0.9 0.1 0.1 33.4
Month 3 137-06 3.5 3.7 1.0 8.9 ND 1.0 4.8 18.8 0.1 ND 34.6
Month 3 138-06 2.4 2.9 25.8 0.6 4.0 7.1 4.1 0.3 ND 44.9
Month 3 139-06 3.4 4.3 19.0 0.3 2.8 4.3 14.8 0.2 ND 45.8
Month 3 141-06 3.6 0.7 8.2 0.1 1.7 1.9 7.9 0.1 ND 20.8
Month 3 142-06 3.8 1.5 14.3 0.3 4.3 3.6 8.2 0.2 ND 32.3
Month 3 143-06 2.8 0.8 8.4 0.1 1.4 1.3 1.5 ND ND 13.5
Month 3 144-06 1.4 0.9 9.7 0.2 1.9 1.5 3.2 ND ND 17.4
Minimum 0.9 0.3 3.8 <DL <DL 0.4 0.8 <DL <DL 6.5
Maximum 6.8 4.3 43.5 1.4 10.2 12.0 81.3 0.5 0.90 118.4
Median 2.9 1.3 12.6 0.2 2.5 2.1 4.7 0.2 0.14 32.8
Mean 3.0 1.6 16.2 0.3 2.8 3.0 10.4 0.2 0.39 34.1
Note. PBDE levels are reported with non-detects fND) = 0; * Data represents the percent llpid content from the statrilltv study
'  Data In the rectangular boxes represents the congener profiles of those samples from the stability study. I 1
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U n iv e r s i t y  of N e w  H a m p s h ire
NAME:


















Start of study 
(date: )
End of study 
(date: )
Would you like a free telephone consultation with a lactation specialist to answer any questions 
you m i^ t  have on breast feeding and breast pump use?
Yes No
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1. Is this your first child? 1. Yes No
If  no, how many other children have you 
delivered? '
2. Is this your first time breast feeding? 2. Yes No
If  no, how many other children have you breast 
fed?
1 Other
How long did you breast feed your 1®* child 
, 2"  ^child
child , 5* child .
,3™ child ,4"'
Please indicate days, months, or years.
3. Is your infant receiving only breast milk? 3. Yes No
If  no, what supplementary feeding(s) are you 
using?
Formula Water Juice Solid Foods
Other__________ ___________ ___
How much per day o f each are you 
supplementing with:
4. White, non-Hispanic O
Hispanic or Latino O
Black or Afiican American O
American Indian O
Alaskan Native ^




4. Please indicate your ethnicity.
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5. Please indicate your level o f education. 5. Less than high school graduate □  
High school diploma or GED □  
Some college or technical school □  
College graduate, 2-year degree □
College graduate, 4-year degree □
Masters degree O
Doctoral degree O
6. Please indicate your total household 
income.
6. Less than $20,000 □
$20,000 to $34,999 □
$35,000 to $49,000 □
$50,000 and higher □
7. Do you engage in physical activity? 7. Yes No
If yes, what category best describes you:
I I Any leisure time physical activity
□  Regular and sustained physical activity 
for 30 minutes or more 5 times per week
I—I Regular and vigorous activity that 
involves large muscle groups for 20 
minutes or more three times per week
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H E A L T H  H IS T O R Y :
Have you been diagnosed by a health care provider with any of the following:
If yes: Type 1 Type 2 Gestational
If yes, current blood pressure:____________
Diabetes Yes No
Asthma Yes No
High Blood Pressure Yes No
Heart Disease Yes No
High Cholesterol Yes No
Digestive Disorders Yes No
Do you have other health issues?
Yes No







If yes, please explain:
Are you currently taking any medications or dietary supplements?
Yes No If yes, please list:___
Are you a vegetarian? Yes No If  yes, do you exclude (circle all that apply):
Red meat Dairy Products Eggs
Fish Poultry
Have you gone on a diet to lose weight in the past three years? Yes 
If  yes, how much weight did you lose?______________________
No
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Before you became pregnant, did you smoke cigarettes? Yes No
a. If yes, how many cigarettes on average did you smoke each day?
b. For how many years had you been smoking?________
Do you currently smoke? Yes No
a. If yes, how many cigarettes per day? ___________
Do you currently live with or share an office with a smoker? Yes No
a. If yes, how many hours per day are you at home or in the office with a smoker?
Is there anything you want to explain regarding your answers?
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A sample of the Food Frequency Questionnaire can be viewed at: 
http://www.fhcrc.org/science/shared_resources/nutrition/
Contact information:
Fred Hutchinson Cancer Research Center 
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U n i v e r s i t y  of N e w  H a m p s h ir e
STEPS TO A HEALTHY FUTURE 
Survey #3: Maternal Environment
Subject #
Today’s Date
R E S ID E N T IA L  IN F O R M A T IO N  
S E C T IO N  A
1. What town do you reside in?
a. How long have you been at your current residence?
b. Prior to this residence, where did you live and for how long?
2. In the past three years, have you lived within a 10 minute walk of an industrial complex? 
(By industrial complex, we mean an area with several manufacturing facilities)
Yes No
If yes, what types o f industries were located in that complex?
3. In the past three years, have you ever lived within a 10 minute walk o f any of the following: 
Yes No
If yes, please check all that apply,
a. incinerator   c. landfill
b. garbage processing facility/recycling center d. sewage treatment plant
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4. Have you ever been in a house, office, or car fire?
Yes No
5. On average, how many hours per day are you at home, including sleeping hours? (Please 
circle one)
a. Less than 9 hours per day
b. 10 to 12 hours per day
c. 13 to 15 hours per day
d. greater than 15 hours per day
6. Are you a stay at home mom? Yes No
i. If  yes, how long have you been a stay at home mom?
( I f  g rea te r th an  1 ye ar skip S E C T IO N  B )
O C C U P A T IO N A L  IN F O R M A T IO N  -  S E C T IO N  B
1. Are you currently working? Yes No
2. Are you on maternity leave from a full-time or part-time job? Yes No
I f  you answered yes to  question 1 o r  2, please com plete questions a. th ro u g h  k .
a. Where do you work? ________________________________________
b. What is your occupation?____________________________________
c. How long have you been at this job?
d. What town do you work in? ______
e. How many days per week do you work?
f. How long do you work each day? _____
g. What kind of work do you do there?_
h. Does this job sometimes involve the manufacturing or processing o f fabrics, plastic, 
or foam? Yes No
i. Does this job sometimes involve working on a computer or copy machine?
Yes No
j. Is there computer equipment, a fax machine, or a copy machine in your office?
Yes No
k. Do you sit on a foam or padded chair? Yes No
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T R A N S P O R T A T IO N  IN F O R M A T IO N  
S E C T IO N  C
1. Do you drive your own car? Yes No
I f  yes, answ er l a  to  c. I f  no, skip to Id .
a. What is the year of the car you most often drive?
b. Does your car have ripped seats or exposed foam? Yes No
c. How many hours per week do you spend in the car?_______________
d. Do you regularly (more than once per week on average) drive or ride in a car other 
than your own? Yes No
I f  yes, answ er le  to g. I f  no, skip to question 2.
e. What is the year of this car?______________
f. Does this car have ripped seats or exposed foam? Yes No
g. How many hours per week do you spend in that car? _______________
2. Do you regularly (once or more per week on average) take the bus or commuter rail?
Yes No
H O U S E H O L D  IN F O R M A T IO N  
S E C T IO N  D
1. How many rooms are in your home (including bathrooms): ___________________
2. Do you have the following products in your home:
a .C u rta in s /V  alences Yes No
i. If yes, how many rooms have curtains? __________________________
b .W a ll to w a ll carp etin g  Yes No
(Note: We don’t mean small area rugs, but carpeting that covers most of the floor 
and is installed with padding underneath)
i. If yes, how many rooms have wall to wall carpeting? _________________
c. H a rd w o o d  flo o rin g  Yes No
i. If yes, how many rooms have hardwood flooring?
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d. Coffee maker Yes No
i. If yes, how often is the coffee maker used?
1. less than I day per week
2. 1 to 3 days per week
3. 3 to 5 days per week
4. 5 to 7 days per week
5. greater than once per day
ii. When was your coffee maker purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984
e. M ic ro w a v e  Yes No
i. If  yes, how often is the microwave used?
1. less than 4 times per week
2. 5 to 6 times per week
3. 1 to 2 times per day
4. greater than 3 times per day
ii. When was your microwave purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984
f. T o aster O ven  Yes No
i. If yes, how often is the toaster oven used?
1. less than 4 times per week
2. 5 to 6 times per week
3. 1 to 2 times per day
4. greater than 3 times per day
ii. When was your toaster oven purchased?
1. 2000 to present
2. 1995 to 1999
3. 1990 to 1994
4. 1985 to 1989
5. Prior to 1984
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g. Hair dryer Yes No
i. If yes, how often is the hair dryer used?
1. less than 1 day per week
2. I to 3 days per week
3. 3 to 5 days per week
4. 5 to 7 days per week
5. greater than once per day






2000 to present 
1995 to 1999 
1990 to 1994 
1985 to 1989 
Prior to 1984
h. Television set Yes No
i. If yes, how many television sets do you have?
ii. When did you purchase each o f your television sets? Place a check 
mark in the appropriate box for each television set.







iii. How often is any television on each day?
1. less than I hour per day
2. 1 to 2 hours per day
3. 2 to 3 hours per day
4. 3 to 4 hours per day
5. greater than 4 hours per day
i. Com puter Yes No
i. If  yes, how many computers do you have?
[One computer is the equivalent of I laptop or 1 desktop (monitor & tower)]
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ii. When did you purchase each of your computers? Place a check mark 
in the appropriate box for each computer.
Com puter
#1












iii. How often is any computer left on each day?
1. less than 1 hour per day
2. 1 to 3 hours per day
3. 3 to 5 hours per day
4. greater than 5 hours per day
j .  C o m p u te r P r in te r  Yes No
i. If  yes, how many printers do you have?
ii. When did you purchase each of your printers? Place a check mark in 
the appropriate box for each printer.
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iii. How often is any printer left on each day?
1. less than 1 hour per day
2. 1 to 3 hours per day
3. 3 to 5 hours per day
4. greater than 5 hours per day
k. Stereo Yes No
i. If yes, which o f the following do you have for a stereo (ind icate  how  
m an y o f  each);
1. All-in-one stereo (i.e. “boom box”)________ _______
2. Receiver _______
3. CD player _______
4. Cassette player _______
5. Speakers_______________________________ _______
6. Other (__________ ) _______
ii. When did you purchase your stereo equipment? Place a check mark 
in the appropriate box for each piece of stereo equipment.







iii. How often is any stereo left on each day?
1. less than 1 hour per day
2. 1 to 3 hours per day
3. 3 to 5 hours per day
4. greater than 5 hours per day
1. Bed M attress (th^t you sleep on) Yes No






2000 to present 
1995 to 1999 
1990 to 1994 
1985 to 1989 
Prior to 1984
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m . What is inside the bed pillows you currently use? Is it;
1. foam
2. down
3. both foam and down
4. not certain
5. other (please specify:_________ J
n. In the past three years, have you had any furniture in your house such as a sofa or 
chair that had crumbling foam?
Yes No
0. Do you have couches with cushions/padding? Yes No
i. If yes, how many couches do you have with cushions/padding?
ii. When did you purchase each of your cushioned/padded couches? 
Place a check mark in the appropriate box for each couch.







p . Do you have liv in g  ro o m /fa m ily  ro o m  chairs with cushions/padding?
Yes No
i. If  yes, how many living room/family room chairs do you have with 
cushions/padding?______________________
ii. When did you purchase each of your cushioned/padded living 
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q. Do you have rocking chairs with cushions/padding? Yes No
i. I f  yes, how many rocking chairs do you have with cushions/padding?
ii. When did you purchase each o f your cushioned/padded rocking 
chairs? Place a check mark in the appropriate box for each rocking 
chair.







r. Do you have kitchen chairs with cushions/padding? Yes No
i. If yes, how many kitchen chairs do you have with cushions/padding?
ii. When did you purchase each of your cushioned/padded kitchen 
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s. Do you have d in in g  ro o m  chairs with cushions/padding? Yes No
i. If  yes, how many dining room chairs do you have with 
cushions/padding?______________________
ii. When did you purchase each of your cushioned/padded dining chairs? 
Place a check mark in the appropriate box for each dining room chair.







t. Do you have desk chairs with cushions/padding? Yes No
i. If yes, how many desk chairs do you have with cushions/padding?
ii. When did you purchase each of your cushioned/padded desk chairs? 
Place a check mark in the appropriate box for each desk chair.
(see next page)
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u. Do you have o th er fu rn itu re  with cushions/padding? Yes No
i. If  yes, please indicate what these furniture pieces are?
ii. When did you purchase each of these pieces? Place a check mark in 
the appropriate box for each piece.
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H O B B IE S /C R A F T /H O M E  IM P R O V E M E N T  IN F O R M A T IO N  
S E C T IO N  E
T h is  section o f questions is about hobbies, crafts , o r w o rk  a ro u n d  the house th a t you m ig ht do 
w hen  yo u ’ re  not a t w o rk .
1. Do you have any hobbies like arts and crafts or model building or do you do any home 
improvement work that involve working with plastic, foam, or fabric?
Yes No
I f  yes:






 Other (Please specify:________________________ )




 Other (Please specify:________________________ )
In  w h a t w ay  do you  w o rk  w ith  fab ric?  C h eck  a ll  th a t ap p ly .
 Sewing clothing
 Furniture repair/reupholstering
 Sewing other household items such as curtains or linens
 Other (Please specify:________________________ )
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Is  th ere  an yth ing  you w an t to exp la in  re g a rd in g  y o u r answers?
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STEPS TO A HEALTHY FUTURE
We would love your feedback!
Feedback Questionnaire for Maternal Environment Survey
1. How long did the Maternal Environment Survey take to complete?
2. Did you have a hard time answering some of the questions?
If yes, please indicate section and question number and WHY.
3. Were any questions confusing?
If yes, please indicate section and question number and WHY.
4. Did you find it helpful to complete the survey in your home?
5 .  D o  y o u  h a v e  a n y  s u g g e s t i o n s  f o r  I m p r o v i n g  t h e  s u r v e y ?
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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T h e  I n s t i t u t i o n a l  R e v i e w  B o a r d  f o r  t h e  P r o t e c t i o n  o f  H u m a n  S u b j e c t s  in  R e s e a r c h  ( I R B )  
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one year from the approval date above. A t  t h e  e n d  o f  t h e  a p p r o v a l  p e r i o d ,  y o u  w i l l  
b e  a s k e d  t o  s u b m i t  a  r e p o r t  w i t h  r e g a r d  t o  t h e  i n v o l v e m e n t  o f  h u m a n  s u b j e c t s  in  t h i s  
s t u d y .  I f  y o u r  s t u d y  is  s t i l l  a c t i v e ,  y o u  m a y  r e q u e s t  a n  e x t e n s i o n  o f  I R B  a p p r o v a l .
R e s e a r c h e r s  w h o  c o n d u c t  s t u d i e s  i n v o l v i n g  h u m a n  s u b j e c t s  h a v e  r e s p o n s i b i l i t i e s  a s  
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Approval Expiration Date: 0 4 / 1 8 / 2 0 0 6  Modification Approval Date: 0 9 / 1 3 / 2 0 0 5
Modification: C h a n g e s  t o  s t u d y  a s  p e r  l e t t e r  t o  I R B  d a t e d  A u g u s t  2 6 ,  2 0 0 5
T h e  I n s t i t u t i o n a l  R e v i e w  B o a r d  f o r  t h e  P r o t e c t i o n  o f  H u m a n  S u b j e c t s  in  R e s e a r c h  ( I R B )  h a s  r e v i e w e d  
a n d  a p p r o v e d  y o u r  m o d i f i c a t i o n  t o  t h i s  s t u d y ,  a s  i n d i c a t e d  a b o v e .  F u r t h e r  c h a n g e s  in  y o u r  s t u d y  m u s t  
b e  s u b m i t t e d  t o  t h e  I R B  f o r  r e v i e w  a n d  a p p r o v a l  p r i o r  t o  i m p l e m e n t a t i o n .
Approval for this protocol expires on the date indicated above. A t  t h e  e n d  o f  t h e  a p p r o v a l  
p e r io d  y o u  w i l l  b e  a s k e d  t o  s u b m i t  a  r e p o r t  w i t h  r e g a r d  t o  t h e  i n v o l v e m e n t  o f  h u m a n  s u b j e c t s  in  t h is  
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R e s e a r c h e r s  w h o  c o n d u c t  s t u d i e s  in v o lv in g  h u m a n  s u b j e c t s  h a v e  r e s p o n s ib i l i t i e s  a s  o u t l i n e d  in  t h e  
d o c u m e n t .  Responsibilities o f Directors o f Research Studies Involving Human Subjects. T h i s  d o c u m e n t  
is  a v a i l a b l e  a t  h t t o : / / w w w . u n h . e d u / o s r / c o m D l i a n c e / i r b . h t m l  o r  f r o m  m e .
I f  y o u  h a v e  q u e s t i o n s  o r  c o n c e r n s  a b o u t  y o u r  s t u d y  o r  t h i s  a p p r o v a l ,  p l e a s e  f e e l  f r e e  t o  c o n t a c t  m e  a t  
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